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PURPOSE: The purposes of this study were to: 1) describe the magnitude and dimensions of 
self-reported fatigue in individuals with knee OA and 2) determine the influence of quadriceps 
fatigue and cardiorespiratory endurance on self-reported fatigue in individuals with knee OA, 
after accounting for potential confounders such as age, sex, pain, depression, and anxiety.  
SUBJECTS: The sample consisted of 44 adults (75% female) with radiographically confirmed 
knee OA.  METHODS: All subjects participated in two testing sessions using a dynamometer 
with a software program developed specifically for this study.  During the first session, subjects 
completed the Multidimensional Assessment of Fatigue Scale (MAF), the WOMAC 
Osteoarthritis Index, the Center for Epidemiologic Studies Depression Scale (CES-D), and the 
Beck Anxiety Inventory Scale (BAI).  A burst superimposition maximum isometric quadriceps 
torque test was performed to determine maximum voluntary isometric contraction (MVIC) 
torque that was used in the quadriceps fatigue test.  In the first testing session, subjects also 
performed a submaximal cycle ergometer test to estimate VO2 max as a measure of 
cardiorespiratory endurance.  Within 1 week of the first session, subjects returned for the 
quadriceps fatigue test in which they performed repeated submaximal contractions equal to 50% 
of their MVIC isometric torque output for 6 seconds followed by a 4-second rest period (duty 
cycle 60%).  The contractions were continued until the subject could no longer generate the 
torque target for 3 successive contractions.  During the sixth contraction and every minute 
 III
thereafter, subjects were instructed to push with a maximum effort and the train of electrical 
stimuli was superimposed upon the maximal effort quadriceps contraction.  Quadriceps fatigue 
was measured as the rate of decline of the MVIC torque output over the course of the test. 
ANALYSIS:  Descriptive statistics were used to describe the magnitude and dimensions of 
fatigue.  An independent samples t-test was used to compare fatigue in individuals with knee OA 
to the levels of fatigue reported by normal controls and individuals with rheumatoid arthritis.  
Hierarchical regression analysis was used to determine the influence of quadriceps fatigue and 
cardiorespiratory endurance self-reported fatigue.  RESULTS:  The mean global fatigue index 
score was 23.6 (SD = 10.4, range 1-40).  Individuals with knee OA reported significantly higher 
fatigue than controls and significantly lower fatigue than RA patients (p < 0.05). Fatigue was 
reported to occur every day by 25% of the sample.  Fatigue most often affected walking, doing 
household chores, shopping, and exercise.  Fatigue was significantly associated with sex (r = .52, 
greater fatigue in females), pain (r = .62), depression (r = .47), anxiety (r = .54), and 
cardiorespiratory endurance (r = -.55) but not to quadriceps fatigue (r= .01).  Hierarchical 
regression analyses revealed that adding quadriceps fatigue or cardiorespiratory endurance to the 
model after controlling for age, sex, pain, depression, and anxiety did not explain any additional 
variance in fatigue, (∆R2 =.00).  CONCLUSION:  Fatigue is common in individuals with knee 
OA. Quadriceps fatigue is not related to self-reported fatigue.  Cardiorespiratory endurance is 
related to self-reported fatigue, but not after controlling for age, sex, pain, depression, and 
anxiety.  CLINICAL RELEVANCE: Management of fatigue in individuals with knee OA may 
require interventions to address psychosocial issues and/or cardiorespiratory endurance. 
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1 INTRODUCTION 
1.1 Overview 
Everyone experiences fatigue occasionally.  It is the body's way of signaling its need for 
rest and sleep.  But when fatigue becomes a persistent feeling of tiredness or exhaustion that 
goes beyond normal sleepiness, it is usually a sign that something more serious is amiss.  In 
healthy individuals, fatigue may result from strenuous physical exercise, a busy day at work, or 
emotional tension.  Fortunately, rest brings relief from fatigue.  Both fatigue and recovery from 
fatigue are normal daily experiences.  Healthy people rarely considered fatigue as a serious 
problem because of the duration of the condition is temporary and the relief measures are 
effective.  In contrast, for those with chronic illness, the cause of fatigue may not be obvious, a 
good night of sleep alone may not completely relieve the fatigue, and fatigue may not be a 
transient condition.  
Chronic illness is a primary health concern.  Individuals with chronic illness face changes 
in lifestyle, and self-esteem, as well as many other physical, psychological, and economic issues.  
Living with chronic illness requires the individuals to manage symptoms and treatments on day-
to-day basis, as well as cope with the demands of daily life.18  Chronic illness is known to affect 
many people. However, it is especially prevalent in individuals aged 65 years and older.61  In 
view of the relationship of chronic illness to aging, it is important to recognize that in the United 
Sates, the number of individuals aged 65 years and older has increased by about 4.5 million 
(12%) in each decade since the World War II, more than twice the rate for the remainder of the 
population.41  In 2000, 35.0 million people 65 years of age and older were counted in the United 
States.56  This represents a 12% increase since 1990, when 31.2 million people 65 years of age 
and older were counted.56  The continued aging of the population will result in a geometric 
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increase in the number of elderly people at risk for disabling chronic illness.  This escalation in 
the elderly population creates an increase in concern for health, wellness, and quality of life 
among the elderly.   
One important and pervasive health concern among the elderly is arthritis.  Arthritis is 
one of the predominant chronic illnesses that affected an estimated 15% of the US population in 
1995 (almost 40 million Americans).  By the year 2020, this number is expected to increase to 
18.2% or nearly 59.4 million Americans.79  Arthritis is the leading cause of disability among 
adults in the United States.27 
Osteoarthritis (OA) is the most prevalent form of arthritis.  In 1990, an estimated 20.7 
million Americans had physician-diagnosed OA and current projections suggest that 
approximately 30 million people in the United States will have OA in the year 2020.79  The 
prevalence of OA is highly correlated with advancing age.  More than 80% of all people over the 
age of 65 years have radiographic evidence of OA.82  Although not all individuals with 
radiographic evidence of OA are symptomatic, 16 million Americans have significant joint pain 
as a result of OA.21,106 
One of the most significant threats to an older person's ability to live and function 
independently is loss of mobility.  Physical disability is an important public health outcome for 
older adults.  OA was shown to have a formidable effect on physical activities and it was deemed 
the second most common cause of disability.54  Given the substantial prevalence of OA in an 
aging population, OA may account for greater loss of independence in activities of daily living 
than any other chronic illness.  Osteoarthritis of the knee is the most prevalent type of OA and 
contributes significantly to functional limitations in performance of weight bearing tasks.54,79  
Osteoarthritis of the knee is particularly disabling because it limits basic, but important to 
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independent living and quality of life, activities of daily living such as, walking, using stairs, 
getting in and out of chairs and vehicles, housekeeping, and carrying bundles.54  At the extreme, 
OA can result in complete debility, with rising from a chair or taking but a few steps becoming 
an agonizingly painful activity.   
Individuals with arthritis are challenged with managing pain, preserving joint mobility 
and function, adhering to exercise programs, pacing activities to conserve energy, and obtaining 
emotional and physical rest.  Fatigue may be a major limiting factor and one of the challenges to 
cope with arthritis because of its interfering with activities of daily living which negatively 
impact the quality of life of individuals with arthritis.  Tasks taken for granted by healthy people 
require special attention for suffers of arthritis. Individuals with arthritis, as compared to healthy 
people, may require extra effort to perform routine activities of daily living (e.g., prolonged 
standing, walking, climbing stairs, and rising from a seated position).  This extra effort may 
induce fatigue more quickly in individuals with arthritis than it does in healthy people.  As a 
result of these constant challenges, fatigue in arthritis has received an increasing research interest 
during the past two decades. 
 
 
1.2 Statement of the Problem 
Fatigue has a special place in rheumatic diseases.  It is one of the most common 
symptoms reported by patients with Systemic Lupus Erythematosus (SLE)24,74,88,115,118,124, 
Fibromyalgia (FM)75,76,93,123 and Rheumatoid Arthritis (RA).12,13,64,101,113,114,123    Fatigue and 
factors contributing to fatigue have been extensively investigated in rheumatic diseases12,13,24,74-
76,93,113-115,118,123,124 except OA.123 The reason for that might be the assumption that the 
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relationship between fatigue and autoimmune disease was thought to be due to the systemic 
nature of the disease.  However, current research has demonstrated that fatigue was not related to 
disease activity.12,12,24,64,118,123   
Out of all rheumatic diseases, RA and OA are the most common joint diseases affecting 
the elderly.79   Both diseases are sharing relatively common clinical manifestations such as pain, 
morning stiffness, joint radiographic changes and psychosocial distress due to functional 
limitations.102  It is estimated that 88-100% of individuals with RA experience fatigue.12,13,123  
Moreover, it was well documented that fatigue in autoimmune diseases such as RA has a strong 
association with disease-related factors such as joint pain and psychosocial variables.12,13,123  
However, these factors are also related to knee OA.   
Given that OA and RA share common disease-related factors (e.g., pain and psychosocial 
distress), this raises a question of whether debilitating fatigue exists in individuals with in knee 
OA and if it does exist, what is the nature of the relationship between fatigue and other factors 
associated with knee OA such as age, sex, pain, depression, anxiety, quadriceps fatigue and 
cardiorespiratory endurance.   
After an extensive and careful review of the literature, it appears that only one study has 
been conducted to address fatigue in individuals with OA.123   This study was limited due to the 
use of a simple unidimensional measure of fatigue (i.e., a Visual Analog Scale (VAS)). The 
magnitude of fatigue in individuals with knee OA has not been thoroughly described and its 
relationship to physiological and psychosocial factors has not been clearly delineated.  Because 
fatigue is a subjective experience, self-report is the most common approach used to measure 
fatigue.  However, self-report measure of fatigue reflects the individual’s perception of his or her 
ability to perform enduring-type tasks, whereas, performance-based measure of fatigue (e.g., 
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muscle fatigue and cardiorespiratory endurance) examine the individual’s ability to complete an 
enduring-type task.100  Therefore, it is imperative to describe the relationship between self-
reported fatigue and a performance-based measure of fatigue to see if the information obtained 
by both measures is complimentary.  
The multidimensionality of fatigue makes it a difficult phenomenon to investigate.  The 
complexity of psychosomatic and somatic factors no doubt account for the dearth of relevant 
studies on the experience of fatigue in OA.  Therefore, it is not surprising to find a paucity of 
information about fatigue in non-systemic diseases such as OA, which have local signs and 
symptoms confined to the affected joint compared to the wealth of information about fatigue in 
autoimmune systemic diseases such as RA. 
 
 
1.3 Purpose of the Study 
The purposes of this study were to; 1) describe the magnitude and dimensions of self-
reported fatigue in individuals with knee OA, 2) determine the influence of the quadriceps 
fatigue on self-reported fatigue in individuals with knee OA, while accounting for potential 
confounders such as age, sex, pain, depression, and anxiety and 3) determine the influence of the 
cardiorespiratory endurance on self-reported fatigue in individuals with knee OA, while 
accounting for potential confounders such as age, sex, pain, depression, and anxiety.  
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1.4 Significance of the Study  
Completion of this study will provide a clearer description of the magnitude and 
dimensions of fatigue in individuals with knee OA and the nature of its relationship with other 
factors such as demographic variables, pain, psychosocial distress, quadriceps fatigue, and 
cardiorespiratory endurance.  If it can be demonstrated that debilitating fatigue is high in 
individuals with knee OA and it is related to the quadriceps fatigue and cardiorespiratory 
endurance, then strategies to manage fatigue in individuals with knee OA and specific 
interventions tailored to reduce the quadriceps fatigue and increase cardiorespiratory endurance 
need to be developed.  
This study contributes significantly to rehabilitation science by describing the magnitude 
and correlates of fatigue in individuals with knee OA.  Because fatigue is a common harbinger of 
the presence of illness and disease progression, the identification of fatigue severity and impact 
is important in clinical monitoring.  Furthermore, these data may draw the attention of clinicians 
and researchers toward this debilitating symptom and provide direction for more effective 
management of patients with knee OA. 
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2 REVIEW OF THE LITERATURE 
2.1 Introduction 
 The review of literature will include the following; 1) definition of fatigue, 2) magnitude 
of fatigue, 3) measurement of fatigue, 4) review of previous studies on the magnitude and 
dimensions of fatigue and variables contributing to fatigue in RA, 5) review of previous research 
addressing fatigue in OA to provide clarity and focus to the research hypotheses, 6) identification 
of variables that may contribute to fatigue in OA, 7) research questions and hypotheses.  
 
2.2 Definition of Fatigue 
 Not surprisingly, defining fatigue, given its complexity, and its multicausal and 
multidimensional nature, has challenged researchers for many years to agree on a universal 
definition.1  Currently, no such definition exists.  Investigators have difficulties in differentiating 
between its causes (e.g., anemia, or depression); its signs and symptoms (e.g., reduction in force, 
legs or whole body); and its outcomes (e.g., decreased activity, functional disability).120 
 Fatigue is defined as the enduring, subjective sensation of generalized tiredness or 
exhaustion.  The term “enduring” connotes that the sensation of fatigue has persisted over a 
period of time.  The term "subjective" implies fatigue is a self-recognized phenomenon 
embedded in the individual's own evaluation of his or her current state.  "Generalized" connotes 
that the sensation encompasses the person as a whole and is not restricted to specific anatomical 
structures, regions, or functions.114   
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2.3 Magnitude of Fatigue  
  Fatigue is a universal symptom not only associated with most acute and chronic 
illnesses, but also with normal, healthy functioning and everyday life.  The US Health and 
Nutrition Survey (NHANES-1) reported fatigue in 20.4% of women and 14.3% of the men in the 
general population.28  Fatigue has been accepted as an almost universal symptom of aging.  
Approximately 70% of all elderly people report that fatigue bothers them, and of that number, 
59% experience it very often.23  It is also a universal human experience that is often overlooked 
as a potentially important symptom of disease.  Indeed, clinical experience suggests that fatigue 
is often the first indication of abnormality but individuals do not mention fatigue unless it is a 
prominent symptom, it is impeding an important aspect of their lives, or they are asked.45  
Therefore, fatigue can be a principal limiting factor for ill, as well as healthy individuals.  
 In clinical settings, fatigue is the most prevalent symptom and often the first indicator of 
physical or mental illness, but unless asked, less than 79% of elderly people will mention it.23   In 
surveys of patients in primary care setting, fatigue was reported by as many as 25% of the 
patients with the mean duration of 3.3 years.57  A British survey of those attending general 
practice found that 18.3% of 15,283 respondents had had substantial fatigue lasting six months or 
longer.95  Fatigue and psychological morbidity were moderately correlated (r = 0.62).  Women 
were more likely to complain of fatigue than men.  Of those reporting fatigue, 56.8% attributed 
their fatigue to psychosocial causes.95  
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2.4 Measurement of Fatigue 
Because fatigue is primarily a subjective experience, self-report is the most common 
approach used to measure fatigue.  Numerous self-report instruments have been developed to 
measure fatigue.  Unfortunately, each of these measures was tailored to the situation in which 
fatigue is studied.  Therefore, each has advantages and disadvantages largely tied to the purpose 
for which it was developed.  
Krupp, et al73, recognizing the complexity and difficulty of defining and studying fatigue 
as a distinct entity developed the Fatigue Severity Scale (FSS).  The FSS was originally used to 
assess disabling fatigue across two different clinical disorders, Multiple Sclerosis (MS) and SLE, 
both chronic illnesses in which fatigue is a common presenting symptom or a chronic and 
disabling problem.  These researchers' use of this scale helped elucidate the relationship of 
fatigue and depressive symptoms and identified features of fatigue that might be characteristic of 
specific diseases.73 
The FSS contains nine statements (e.g., "My motivation is lower when I am fatigued”, “I 
am easily fatigued”, “Fatigue causes frequent problems for me." etc.).  Subjects choose a number 
from 1 (strongly disagree) to 7 (strongly agree) to indicate agreement/disagreement with each 
statement.  Krupp et al73 reported high internal consistency reliability (Cronbach's alpha =.88) for 
the FSS and high concurrent validity as estimated by the correlation of the FSS with a visual 
analogue scale of fatigue (r =.68, p<.001). 
Given the multidimensionality nature of fatigue, a more comprehensive measure of 
fatigue is needed to address all possible dimensions of fatigue.  Piper et al98 conceptualizes the 
sensation of fatigue as having four dimensions: temporal, intensity/severity, affective, and 
sensory.  The Piper Fatigue Scale (PFS), a self-report scale that measures multiple dimensions of 
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subjective fatigue has been developed for research with cancer patients receiving radiation 
therapy.98  The PFS uses 41 different 100-mm VASs to measure subjectively reported fatigue 
across the four primary dimensions: 1) temporal (i.e., timing, frequency, and duration of fatigue, 
2) intensity/severity (i.e., severity and degree of disruption in activities of daily living), 3) 
affective (i.e., emotional meaning attributed to fatigue) and 4) sensory (i.e., physical, emotional, 
and mental symptoms of fatigue).  
The PFS reliability and validity estimates have been calculated in a sample of cancer 
patients receiving radiation therapy.  High internal consistency reliability (Cronbach's alpha = 
.95) was reported for the total fatigue score.  Pearson correlations indicated that the PFS 
demonstrates convergent validity with the Fatigue Symptom Checklist (r =.47, p<.01) and 
divergent validity with the Profile of Mood States (POMS) vigor subscale (r = -.57, p<.001).98 
The multiple dimensions of subjective fatigue also can be measured by the 
Multidimensional Assessment of Fatigue (MAF) that has been developed for research involving 
patients with rheumatoid arthritis.12   The scale has 16 items that measures five dimensions of 
fatigue: degree (item 1), severity (item 2), distress (item 3), degree of interference with activities 
of daily living (items 4-14), and timing (items 15-16).  Fourteen items contain 10-point 
numerical rating scales (items 1-14) and two items have multiple-choice responses (items 15-16).  
The 10-point numerical rating scale ranges from 1(not at all) to 10 (a great deal). Respondents 
are asked to reflect on fatigue patterns for the past week.  Scoring the MAF results in the Global 
Fatigue Index (GFI), which ranges from 1 (no fatigue) to 50 (extreme fatigue).  The Cronbach's 
alpha was 0.93 when this measure was tested on group of 51 individuals with RA and 26 age and 
sex matched controls.12  Belza12 reported convergent validity of the MAF with the POMS fatigue 
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subscale (r=0.84,  p<0.01) and divergent validity with the POMS vigor subscale (r=-0.62,  
p<0.01). 
The MAF scale is a good choice when selecting an instrument to measure fatigue in 
chronic illness as it is: easy to administer and score, relatively short in length (it takes less than 
five minutes to complete) and assesses the subjective aspects of fatigue including degree, 
severity, distress, impact, and timing.  The questionnaire allows patients to omit activity items 
that do not apply, thus making it a more accurate assessment of the impact of fatigue on activities 
of daily living (ADLs).  To yield reliable and valid responses, instructions are included on page 
one of the three-page instrument.  The instructions read: "These questions are about fatigue and 
the effect of fatigue on your activities during the past week".  If no fatigue is reported (i.e., 
respondents answer (item 1) by indicating they have not had any fatigue in the past week) then 
they are instructed to stop.  The reason to stop is because items 2-16 are only applicable if the 
respondent had fatigue in the past week.  So as to assure variability in the outcome variable of 
fatigue, respondents who report no fatigue are assigned a zero score for items 2-16 and kept in 
the analysis. This scale was used in this study as it assesses the multiple dimensions of fatigue 
and was tested on patients with RA that have functional limitations and complaints of fatigue, 
similar to patients with OA.  A complete description of how to score the MAF results into the 
GFI is found in chapter III.   
 
2.5 Fatigue in Rheumatoid Arthritis   
Although the primary symptoms of RA are in the joints, the systemic nature of the 
disease produces extraarticular symptoms, such as fatigue.  Existing in all gradations of RA, 
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fatigue is increased during flares and minimally present during remissions.  In fact, the presence 
of fatigue is considered a prodromal symptom of RA and the absence of fatigue is a criterion for 
disease remission.97  In rheumatic disorders, fatigue may be prominent even when the patient has 
not been active physically.  Indeed, fatigue in RA patients may be sensed when they are resting, 
and it is experienced as an aversion to activity.92 
In a study of fatigue in 20 outpatients with RA, 19 patients reported having experienced 
fatigue and 57% of these subjects reported fatigue to be the most problematic aspect of having 
RA.113  Respondents reported that their fatigue may have a sudden or gradual onset, may be 
predictable or unpredictable, may be dull or intense in severity, and may have a short or long 
duration.  They felt that the frequency and duration of their fatigue varied based on several 
factors including physical factors (e.g., arthritis disease activity), psychological factors (e.g., 
emotional stress), environmental factors (e.g., work setting), and treatment (e.g., dose of 
steroids).  Indeed, Tack (1990)113 found that fatigue, pain, and depression are significantly and 
positively correlated, suggesting that an increase in pain, depression, or fatigue is associated with 
an increase in the other variables. 
Because of the relatively small sample size and the use of basic descriptive statistics and 
very lengthy and difficult to administer measure of fatigue (i.e., POMS; consists of 65 items) the 
generalizibilty of that study was limited.  Belza et al13, subsequently developed the MAF and 
used it in a study of fatigue in 133 individuals with RA.  Ninety-three percent of the sample 
reported experiencing fatigue during the past week.  Forty percent of the sample reported that 
fatigue occurred every day.  About half the sample (48%) reported fatigue was unchanged during 
the course of week, and most often fatigue affected walking, doing household chores, and 
shopping.  
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In another study of fatigue, Belza et al12, compared fatigue in 51 patients with RA (age 
ranged 21-55) with 46 age-and sex-matched controls without RA.  All patients with RA reported 
some degree of fatigue in the week before completing the questionnaire.  Thirty-five of the 46 
(76%) of the controls reported fatigue within the past week.  The difference in proportion was 
significant (p<.001).  Patients with RA reported statistically significant higher fatigue scores on 
the MAF scale than age-and sex-matched controls. The mean GFI scores for patients with RA 
was 27.8 ± 10.5, whereas for the controls it was 16.4 ± 11.5 (p <.001).  On a 10-point numerical 
rating scale (1=not at all and 10=a great deal), patients with RA reported a moderate to high 
degree of fatigue (mean =6.3, SD=1.7), moderate fatigue severity (mean= 5.4, SD=1.8) and 
moderate distress from fatigue (mean=4.9, SD=2.3).  For half of the patients, fatigue occurred 
most or every day of the week before completing the questionnaire.  The average impact of 
fatigue on ADL was 4.2±2.1.  Fatigue most often affected exercise (mean= 5.3, SD=2.7), leisure 
(mean= 4.8, SD=2.8) and shopping (mean=4.6, SD=2.3).      
Recently, Wolfe et al123, conducted a study on 1488 patients with 3 rheumatic diseases 
(RA, OA and FM) to determine the prevalence of fatigue in these disorders.  Fatigue in this study 
was measured by a double anchored VAS labeled at one end "Fatigue is no problem," and at the 
other end, "Fatigue is a major problem."  The question read, "How much of a problem has 
fatigue or tiredness been for you in the past week?".  The scale for the response categories range 
from 0 to 3.  Clinically important levels of fatigue were considered to be greater than or equal to 
2 on VAS scale.  The findings showed that fatigue was present in 88.4% of the RA patients (n = 
628), but substantial fatigue (≥ 2 on VAS) was present in only 41% of the RA patients.  Fatigue 
was also present in 90.1% and 98.2% of the OA (n =535) and FM (n =325) patients, respectively. 
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However, substantial fatigue was present in only 41% of the OA patients and 76% of the FM 
patients. 
What causes fatigue in RA?.  It would seem reasonable to assume, given the prevalence 
of fatigue in RA that fatigue is related to inflammation.  This leads to the hypothesis that fatigue 
will diminish as inflammation decreases.  If this hypothesis is correct, then patients with 
noninflammatory disorders, such as OA should have less fatigue, but this has not been 
extensively investigated.  Several reports dispelled this hypothesis and demonstrated that the 
inflammatory process was not associated with fatigue in RA.12,13,64,123  In fact, they showed that 
disease-related factors such as pain, depression, sleep disturbance and functional disability were 
highly associated with fatigue and independently predicted fatigue.13,64,123  Belza and associates13 
in their study of fatigue in RA used a hierarchical regression to study this question.  They found 
that 61% of the variance in fatigue could be explained by pain (19%), sex (13%), sleep (8%), 
activity level (4%), cormorbid conditions (4%), and functional status (4%).  Pain, sex, and sleep 
quality were found to be the best predictors of fatigue.  Other studies64,123 also found pain, 
depression, sleep disturbance, functional disability and sex were the best predictors of fatigue in 
RA and they developed the best model that explained 53%64 and 49%123 of the variance in 
fatigue.  In the study by Wolfe et al123, 90% of the 49% of the variance accounted for by the 
model was explained by pain, sleep disturbance, and depression.  
 
2.6 Fatigue in Knee Osteoarthritis 
Knee OA may be seen as a different case, where the cause of almost universal fatigue is 
not known, but in which factors such as pain, psychosocial distress, reduced muscle function, 
and reduced aerobic capacity may play important roles.  After a careful review of the literature, it 
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appears that only one study has been conducted to address fatigue in individuals with OA.123   
Despite the limitation of using a simple unidimensional measure of fatigue (i.e., VAS), Wolfe et 
al123,  reported that more than 41% of patients with OA had substantial, clinically important 
fatigue and 90% of the variance in fatigue in OA was explained by pain, sleep disturbance, and 
depression.  
In our clinic, patients with knee OA often report fatigue when they attempt to perform 
activities of daily living that require them to stand for a long period of time or to perform simple 
activities such as walking.  Stair climbing was ranked by individuals with knee OA as the most 
common cause of pain and fatigue.  While this can be partially explained by the relationship of 
fatigue to pain, muscular dysfunction and reduced aerobic capacity ascribed to inactivity may 
also play important roles.  In preliminary work, we found that individuals with knee OA had 
lower scores on the vitality subscale of the Medical Outcomes Study 36-Item Short Form Health 
Survey (SF-36) than age-and sex-matched controls (57.4 ± 21.70 vs. 71.8 ± 22.86, respectively,  
p = .013).  The vitality subscale of the SF-36 is a four-item measure of energy level and fatigue. 
Scores for the vitality subscale range from 0 to 100, where 0 indicates feeling tired and worn out 
all of the time and 100 indicates feeling full of pep and energy all of the time.  
To compare the vitality scores of our sample with the US population normative data, 
standardized scores were created for the 25 randomly selected individuals with knee OA and the 
age-and sex-matched controls using the age-and sex-matched US population means and standard 
deviations (SF-36 Survey Manual).  The average standardized vitality score for the controls was 
on the order of .54 and the average standardized score for the age-and sex-matched subjects with 
knee OA was on the order of -.11.  This means that the OA group in our sample felt relatively 
more fatigue than the age-and sex-matched US population, whereas the controls were less 
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fatigued.  A paired t-test revealed a significant difference between the two groups after 
normalization to the US population (p = .015).   
Moreover, the vitality subscale scores for individuals with knee OA (n=84) in our sample 
were found to be negatively correlated with pain measured by the pain subscale of WOMAC (r = 
-.46, p<.001), depression measured by the Center of Epidemiological Studies Depression Scale 
(CES-D) (r = -.57, p<.001) and anxiety measured by the Beck Anxiety Inventory (BAI) (r = -.49, 
p<.001).  These findings suggested potential relationships between pain, depression, anxiety, and 
fatigue in people with knee OA, but this was not substantiated with another study that was 
specifically designed to investigate fatigue in OA.  
 
 
2.7 Variables Contributing to Fatigue 
The subsequent section focuses on identification of disease-related factors such as; pain, 
depression, anxiety, muscle dysfunction and decreased cardiorespiratory endurance that may 
contribute to fatigue in OA. 
 
 
2.7.1 Pain 
Pain is the most important symptom of OA and is the principal reason why individuals 
seek medical care, which may include major interventions such as joint replacement.  Patients 
with knee OA and their care providers discuss pain at 98% of all visits.60  McKenna & Wright 
surveyed a heterogeneous sample of individuals with arthritis and found that 75% of those with 
OA ranked pain as the most important symptom to be treated.86  The origin of pain in knee OA is 
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unclear since cartilage, the target of the disease, lacks innervation.  Effects of the OA to the 
adjacent structures are thought to contribute to the pain.  These include; synovitis; distension of 
the joint capsule (which is innervated) due to joint deformity; periosteal elevation from bony 
proliferation; ischemia and pressure in subchondral bone (also innervated); muscle spasm; and 
damage to periarticular structures, such as ligaments, tendons, and fascia.30  Early in the course 
of the disease, individuals may report poorly localized, asymmetric, and episodic pain that is 
nagging and aching.  As the disease progresses, reports of severity and frequency of pain 
increase.  Pain is typically worse with activity and relieved by rest.  In advanced disease, 
however, the individual may be kept awake at night by the pain.16 
 
2.7.1.1 Pain and Functional Limitation  
Pain can be the principal cause for functional limitation in individuals with knee OA.  
The severity of pain will cause people to be reluctant to move the joint.  A vicious cycle may be 
initiated in which pain leads to decreased movement that in turn leads to stiffness and immobility 
of the joint.  The associated inactivity can lead to muscle weakness, and muscle fatigue which in 
turn lead to less joint protection and a greater tendency to injure the joint during weight-bearing 
activities.  Injury increases pain and the cycle starts again.44  
Pain is also a risk factor for disability both in cross-sectional and longitudinal studies.  
Most show that with increasing severity of knee pain in individuals with knee OA, there is an 
increase in the self-reported physical disability.62,67,78  Using data from the Johnston County 
Osteoarthritis Project, a community based sample of African-Americans and Caucasians aged 45 
years and older in rural North Carolina, Jordan et al67,  reported that knee pain severity was 
strongly associated with overall self-reported disability measured by mean Health Assessment 
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Questionnaire (HAQ) score.  In addition, they noted that the difference in mean HAQ scores 
between those with and without radiographic knee OA was not independent of knee pain, 
sociodemographic factors, and obesity.  Based on these observations, they concluded that knee 
pain severity was more important than radiographic knee OA severity in determining disability. 
In another community-based study, results showed that physical disability measured by 
the Sickness Impact Profile (SIP), a more general health questionnaire than the HAQ, in patients 
with knee OA age 55-74 years old was significantly associated with the chronicity and severity 
of knee pain.  The mean of physical disability in the group with chronic and severe knee pain 
was 5.4 times higher than in an age-and sex-matched control group.62  Data from the first 
National Health and Nutrition Examination Survey (NHANES-1) Epidemiologic Follow-up 
Study (1971-1975), showed that baseline knee pain in individuals with knee OA was associated 
with increased risk of difficulties with functional activity 7-13 years later, irrespective of 
baseline radiographic changes.78  
  
2.7.1.2 Pain and Fatigue  
There is a consensus in the literature that fatigue is significantly correlated with 
pain.12,32,64,122,123  Huyser et al64 reported a moderate correlation (r = .49) between fatigue 
measured by the PFS and pain measured by the McGill Pain Questionnaire (MPQ) in 73 patients 
with RA.  Wolfe et al123, found fatigue as measured by a VAS was associated with pain as 
measured by a VAS (r = .57) in 1488 patients with rheumatic diseases (RA, OA, and FM).  Belza 
et al12, reported an association between fatigue measured by the MAF and pain measured by a 
VAS (r = .48) in 51 patients with RA.  Wolf122, found that fatigue measured by a 15 cm VAS 
was correlated with pain measured by the WOMAC (r =0.60) in 2115 patients with RA, OA and 
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FM.  Creamer et al32, studying a group of hospital outpatients with knee OA, found that fatigue 
measured by the MPQ was significantly related to pain (r = 0.34) measured by the FSS.  
Pain may contribute to fatigue through several mechanisms.  First, dealing with severe or 
unusual amounts of pain requires additional physical and emotional energy.  Second, extra steps 
(requiring more energy) may be needed to complete a task in manner causing the least pain.  
Third, pain may interfere with a restful night of sleep, thereby resulting in daytime fatigue.85 
The precedent review provided a brief description of the effect of knee joint pain on 
individuals with knee OA.  Pain is the most important symptom of OA and is the major reason 
why individuals seek medical attention, which may include major interventions such as joint 
replacement.  Pain is also a major determinant of loss of function in individuals with OA.  
Individuals with OA may limit their functional activities to avoid movements that exacerbate 
pain.  Pain is typically worse with activity, relieved by rest, and results from compression or 
shearing stresses on exposed subchondral bone.  Inactivity may lead to more deconditioning and 
muscle dysfunction which may contribute to fatigue during ADL.  Given the lack of disease-
modifying drugs for OA, the goal of treatment is to minimize pain associated with OA and its 
impact on patient function and quality of life.  Fatigue is strongly related to pain.  
 
 
2.7.2 Depression and Anxiety 
The expression of psychological reactions, notably depression and anxiety, in patients 
with knee OA is not surprising, given the amount and persistence of pain and disability they 
experience, and the uncertainty about what the future might hold for them.  Depression or 
anxiety are frequently expressed when a person fails to cope with the pain and disability 
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resulting from OA.20  As the disease progresses, knee pain persists and becomes chronic which 
may trigger anxiety and avoidance of movement as a normal response to protect the knee and the 
individual may become worried about the loss of function he or she will encounter in the future.  
Sleep-interrupting pain increases fatigue, and individuals may feel helpless about what is 
perceived as an additional burden to the normal demands of daily living.  Most individuals with 
knee OA are elderly and are likely to have some age-related comorbidity; knee pain provides an 
additional health problem.         
Depression and anxiety have been shown to be higher in patients with knee OA compared 
to age-and sex-matched controls.22,83   Individuals with knee OA were found to be over three 
times as likely as age-and sex-matched controls who do not have OA to have a depressed 
mood.83   In a longitudinal study22, patients with knee OA reported higher depression scores 
measured by the CES-D than age-and sex-matched controls at both baseline and average 31 
months follow-up.  Recently, we investigated depression (measured by the CES-D) and anxiety 
(measured by the BAI) in elderly subjects (mean age 60 years) (Irrgang et al, unpublished data).  
The subjects included 84 individuals diagnosed with knee OA, and 25 subjects without OA who 
were matched on age and sex with a randomly selected subset of subjects from the OA group.  
Individuals with knee OA scored higher than age-and sex-matched controls for both the mean 
depression score (7.64 ± 6.29 and 5.12 ± 6.16, p=.148) and the mean anxiety score (3.80 ± 4.30 
and 2.6 ± 3.41, p=.329).  Although the difference in the mean depression score was not 
significant between the OA group and age-and sex-matched controls, 14% of OA group 
compared to 3% of age-and sex-matched controls scored 16 or above on CES-D that qualified 
them to be possibly depressed as defined by Radloff in 1977.99  However, the difference in 
proportions was not significant (p=.375).  The insignificant differences in the mean depression 
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and anxiety scores and the proportions of depressed or anxious individuals found between the 
OA group and age-and sex-matched controls may be attributed to the small sample used for 
matching.    
 
2.7.2.1 Depression, Anxiety and Pain 
A number of studies have linked psychological factors and the presence or absence of 
pain22,31,35,59, and pain severity62,105,112 in individuals with knee OA.  Brandt et al22, attempted to 
determine if depression scores (measured by the CES-D) in subjects with knee pain but not 
radiographic evidence of OA are different from those of subjects with symptomatic knee OA.  
They found that, in contrast to those with symptomatic knee OA, women who had knee pain but 
no radiographic evidence of OA had CES-D scores high enough to qualify for a diagnosis of 
clinical depression.  The mean CES-D score for women with knee pain but no radiographic 
evidence of OA was significantly greater than that for women with symptomatic knee OA.  
However, this relationship did not exist for men.   
In a community study, Creamer et al31 investigated the relationship of depression and 
anxiety with reported knee pain in individuals with knee OA who participated in the Baltimore 
Longitudinal Study of Aging.  Knee pain was defined by the NHANES-1 question "have you 
ever had pain in or around your knee on most days for at least one month?".  Depression and 
anxiety were measured by the relevant subscales of Arthritis Impact Measurement Scales 
(AIMS) questionnaire.  After adjustment for age, they found that among women who reported 
"ever" having knee pain without radiographic evidence of OA, anxiety scores were higher than 
those of women that reported "never" having pain.  In this study, depression was not 
significantly related to knee pain.  
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Hochberg et al59 reporting data from the NHANES-1 cohort, found that 49% of white 
women with knee pain reported feeling “low or very low in spirits" compared with 33% of those 
without knee pain.  Further reports from the same cohort, using the General Well-Being Index, 
found that psychological status was positively associated with knee pain independent of 
radiographic changes.35  Of the 6 General Well-Being subscales, the "energy level" and "freedom 
from health worry" subscales were most consistently related to knee pain, but "cheerful versus 
depressed mood" and "relaxed versus anxious" were also associated.  They suggested that 
General Well-Being was related to pain in subjects both with and without radiographic changes 
of knee OA.   
Other studies have examined the relationship between psychological factors and pain 
severity, rather than the presence or absence of knee pain.  In a community survey of 306 elderly 
(mean age 65.5 years) the relationship of chronicity and severity of pain to psychosocial 
disability (as measured by the subscales of the SIP,) was explored.62  The chronicity and severity 
of pain were associated with higher psychosocial disability when compared with age and sex 
matched pain free controls from the same community.  The mean of psychosocial disability in 
the group with chronic and severe knee pain was 3.6 times higher than age and sex matched 
control group. 
In a study of 61 patients with knee OA (mean age 63.5 years) Salaffi et al105, found 
significant correlations between pain measured by the MPQ and Zung Anxiety and Depression 
Inventory scores.  The strongest correlations were between affective pain and anxiety (r = 0.56) 
and depression (r =0.62).  Summers et al112 reporting on 65 patients with hip or knee OA (mean 
age 71 year), found that depression (as measured by the Beck Depression Inventory) and anxiety 
(measured by the State-Trait Anxiety Index (STAI)) correlated with pain measured by the MPQ.  
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In our preliminary work, we found significant correlations between knee pain severity (as 
measured by the pain subscale of WOMAC) and depression (measured by the CES-D) and 
anxiety (measured by the BAI).  In OA group (N=84), knee pain was significantly correlated 
with depression (r = .26, p= .008) and anxiety (r = .34, p =.001).   
 
2.7.2.2 Depression, Anxiety and Fatigue 
 Fatigue was first described clinically, in the early 1900s, as a "generalized neurasthenia" 
or weakness of the body.  If reviewed today, many of those early cases would be described as 
psychological disorders.53  In fact, fatigue is often a significant component in affective and 
anxiety disorders.  Fatigue or loss of energy nearly every day is a hallmark diagnostic criterion 
for a major depressive episode.110  Furthermore, fatigue may be magnified by poor psychological 
status, particularly in a patient who feels worthless when he or she has no strength.  In addition to 
experiencing hopelessness, the depressed patient may have a sensation that great effort is 
necessary to initiate action.  In general, fatigue may be deemed as a manifestation of 
psychological problems.   
 Several reports found psychological problems to be strongly associated with fatigue in 
collections of rheumatic disorders.12,13,64,123  Fatigue (measured by the PFS) was found to be 
strongly correlated with depression (measured by the CES-D) and anxiety (measured by the 
STAI) (r = .51, r = .41, respectively) in a group of patients with RA.64   In another group of RA 
patients, Belza12 reported a high correlation between fatigue (measured by the MAF) and 
depression (measured by the depression subscale of POMS) (r = .47).  Wolfe et al123, found 
fatigue assessed by a VAS was strongly associated with the AIMS depression (r = .50) and 
AIMS anxiety scales (r =.52) in 1488 patients with rheumatic diseases (RA, OA, and FM). 
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The mechanisms by which these psychosocial factors contribute to fatigue are not clear.  
However, it has been hypothesized that patients with knee OA tend to avoid physical activity 
because increased levels of physical activity are associated with pain.36  This in turn contributes 
to progressive muscle weakness and fatigue and disability.  As a result, patients may feel 
frustrated and hopeless of this vicious cycle and be at risk of developing psychological distress.  
Depression and anxiety may serve to amplify this loop by increasing the degree of avoidance.  
Prolonged depression and anxiety may, by resulting in persistent attempts to avoid knee pain, 
lead to further muscle wasting, cardiovascular deconditioning and a sensation of generalized 
fatigue during normal activities of daily living.  
 In summary, depression and anxiety are frequently expressed when a person fails to cope 
with the pain and disability resulting from OA.  Depression and anxiety have been shown to be 
higher in patients with knee OA compared to age-and sex-matched controls. Depression and 
anxiety were found to be strongly associated with fatigue in collections of rheumatic disorders.  
These psychosocial variables contribute to fatigue by causing the individual with knee OA to be 
reluctant to move due to pain which leads to muscle dysfunction and decreased aerobic capacity 
which eventually lead to a sensation fatigue of generalized fatigue.  
 
 
2.7.3 Quadriceps Fatigue 
 
2.7.3.1 Definition  
A conclusive definition of muscle fatigue does not exist because it is dependent upon the 
type of task performed (i.e., high or submaximal intensity, intermittent or sustained).40  However, 
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muscle fatigue can be operationally defined as a progressive decline in maximal muscle force 
generating capacity during physical activity.15  The development of this progressive decline in 
force is a complex process and results from multiple factors.  Bigland-Ritchie and Woods15 
classified the mechanisms of muscle fatigue as failure of: 1) excitatory input to higher motor 
centers; 2) excitatory drive to lower motor neurons; 3) motor neuron excitability; 4) 
neuromuscular transmission; 5) sarcolemmal excitability; 6) excitation - contraction coupling; 7) 
contractile mechanisms, and 8) metabolic energy supply and metabolite accumulation.   
Muscle fatigue has frequently been classified as central or peripheral fatigue.42  Central 
fatigue involves failure of motor drive from the central nervous system that results in a reduction 
of the number of functioning motor units and/or a reduction in motor unit firing rate.42  
Peripheral fatigue, on the other hand, occurs within the muscle itself and involves failure of force 
generating capacity of the whole muscle due to failure of the muscle action potential, impaired 
excitation-contraction coupling, depletion of active muscle metabolic energy supply or 
metabolite accumulation.15,42,116
 
2.7.3.2 Quadriceps Fatigue in Knee Osteoarthritis 
Quadriceps fatigue is another symptom often reported by patients with knee OA.46-50,94   
Since quadriceps fatigue may limit the time a person can stand, the distance a person can 
ambulate, or the number of stairs a person can ascend or descend, it may play a major role in the 
reduced functional performance and disability experienced by individuals with knee OA.  
Previous studies have shown that improvements in quadriceps muscle function (i.e., strength and 
endurance) resulted in significant improvements in functional performance in knee OA 
patients.47,49   In spite of the profound clinical implications of quadriceps fatigue in individuals 
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with knee OA, there is a paucity of published data on the effects of knee OA on quadriceps 
muscle endurance.  
Few studies have investigated the effect of knee OA on quadriceps fatigue.48,94   In these 
investigations, quadriceps fatigue was assessed by determining an individual’s ability to sustain a 
maximal isometric contraction for 90 seconds48 or 120  seconds.94  Fisher and Pendergrast48 
measured fatigue as the area under the fatigue curve or the tension-time index.  Nordesjo et al94 
measured fatigue as the steepness of the torque curve or the difference in maximal isometric 
torque between 0 and 120 seconds.     
The relationship between knee OA and quadriceps fatigue is unclear.  Fisher and 
Pendergrast48  found that individuals with knee OA exhibited 203% greater quadriceps fatigue 
than did individuals without knee OA.  Nordesjo et al94  found the endurance curve to be steeper 
on the non-involved side in individuals with unilateral knee OA, indicating less quadriceps 
fatigue on the side with OA.   
The functional significance of quadriceps fatigue is also unclear.  Quadriceps fatigue has 
been found to be related to the time required to walk 50 ft, but not to the degree of dependence, 
difficulty, or pain experienced during a variety of daily activities.48  The failure to demonstrate 
the functional significance of quadriceps fatigue, measured as the ability to maintain a maximal 
isometric contraction for 90 to 120 seconds, may be due to the fact that most daily activities do 
not require a single maximal isometric contraction of the quadriceps.  The ability to sustain a 
single maximal isometric contraction may be influenced by many other factors including pain 
tolerance, ischemia, and motivation.  A single maximal isometric contraction may also create an 
unsafe increase in heart rate and blood pressure.  The demands of normal daily functional 
activities on muscles are more closely reproduced by repetitive, submaximal exercise.  
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To measure quadriceps fatigue in individuals with knee OA, we developed a fatigue test 
that consisted of repeated submaximal quadriceps contractions at 50% of maximal effort 
(unpublished data).  Fatigue was operationally defined as the number of contractions an 
individual could perform before they were no longer able to generate 50% of the maximum 
isometric quadriceps torque.  Using this procedure, we tested 84 subjects diagnosed with knee 
OA, and 25 subjects without OA who were matched on age and sex with a randomly selected 
subset of subjects from the OA group.  The findings from this study demonstrated that 
individuals with knee OA performed significantly more repetitions indicating less quadriceps 
fatigue than control subjects (72.96 + 60.03 and 42.20 + 42.64 respectively, p=.014).  In 
addition, the number of repetitions was not correlated with concurrent self-reported or 
performance-based measures of physical function.  Concurrent self-reported measures of 
physical function included the WOMAC physical function and total scores, the Activities of 
Daily Living Scale (ADLS) of the Knee Outcome Survey, and the physical components 
summary scores of the SF-36.  The "get-up and go" test was used as the performance-based 
measure of physical function.  With this fatigue test, we were unable to demonstrate that 
individuals with knee OA had greater quadriceps fatigue than age-and sex-matched controls.  It 
is unknown if subjects with knee OA truly have less quadriceps fatigue than age and sex matched 
controls or if the measure of fatigue in this study was not a valid measure of quadriceps fatigue.  
With the technique that we used to measure quadriceps fatigue, we were unable to determine the 
mechanisms of fatigue, if any.  The conflicting findings of the studies that investigated the effect 
of knee OA on quadriceps fatigue may be due to the way quadriceps fatigue was operationally 
defined and measured in each of these studies.  Alternative methods are needed to measure 
quadriceps fatigue.   
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2.7.3.3 Quadriceps Fatigue Measurement 
To obtain more insight into the causes of muscle fatigue, it is important to determine the 
mechanisms of muscle fatigue.  Based on the definition of muscle fatigue, it is possible to 
quantify muscle fatigue by having the subject performing brief maximum voluntary contractions 
at regular intervals during repeated, submaximal, intermittent, isometric contractions.  The 
progressive decline of the maximum voluntary contractions over the course of time will be 
defined as muscle fatigue.  Direct electrical stimulation of the muscle will elicit involuntary force 
output.  Comparison of the rate of decline in maximal voluntary contractions with the rate of 
decline in electrically elicited force output allow one to distinguish between muscle fatigue 
caused by reduced motor drive from central nervous system (i.e., central fatigue) and muscle 
fatigue caused by the inability of the muscle itself to generate force (peripheral 
fatigue).14,39,65,69,87,90,117   If a parallel decline in the maximal voluntary contraction and 
electrically elicited force output is observed, it would indicate that the central nervous system is 
still capable of fully activating the muscle and any observed muscle fatigue would likely be due 
to failure of contractile properties within the muscle (i.e., peripheral fatigue).  On the other hand, 
if slopes declined at different rates, than the observed fatigue would be likely due to failure of 
neural drive of the muscle from the central nervous system (i.e., central fatigue).    
Several studies have investigated quadriceps fatigue using the aforementioned technique 
14, 39,65,90,117    Bigland-Ritchie et al14 and Vollestad et al117, have used the technique to assess 
quadriceps fatigue evoked by intermittent submaximal voluntary isometric contractions in young 
healthy subjects. Subjects were asked to hold a targeted force level for 6 seconds (e.g., 50% of 
maximal voluntary contraction), then to rest for 4 seconds.  The subjects repeated this 10-second 
cycle until they could no longer generate and maintain the targeted force level.  Every minute 
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during the test, the subject performed a maximal voluntary isometric contraction, upon which a 
supra-maximal electrical stimulus was applied.  This was then followed by an electrical stimulus 
delivered to the resting quadriceps muscle.  Over a course of time, the rate of decline of the 
maximal voluntary contraction force output was compared to the electrically elicited force output 
from a relaxed quadriceps muscle.  The results indicated that the slope of both force outputs 
declined at a similar rate, suggesting that the source of the fatigue was peripheral.  Other 
investigators used the same technique to assess quadriceps fatigue in subjects with FM90 and 
Addison's disease.65 To the best of our knowledge, no published data on using the above 
technique to quantify quadriceps fatigue in individuals with knee OA. 
 
2.7.3.4 Quadriceps Fatigue and Self-Reported Fatigue 
The association between quadriceps fatigue and sensation of generalized fatigue has not 
been reported. However, it can be assumed by looking at the effect of quadriceps fatigue on the 
neuromuscular control of the lower limb.  It has been demonstrated in young healthy subjects 
that neuromuscular control of the lower limb is compromised in the fatigued state.66,121  Johnston 
et al66 investigated the effect of lower limb fatigue on lower extremity balance as a mean of 
quantifying neuromuscular control of the knee in 20 healthy subjects.  They found that after 
fatiguing exercise on a lower limb dynamometer to less than 50% of original strength values, 
subjects had a significantly decreased ability to maintain balance on one or both legs.  Wojtys et 
al121 investigated the effect of quadriceps and hamstring muscle fatigue on anterior tibial 
translation and muscle reaction time in 10 healthy subjects.  They defined muscle reaction time 
as the time between onset of passive anterior tibial translation and onset of muscle firing.  They 
found an average increase of 32.5% in anterior tibial translation, a delay in muscle reaction 
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times, decreased firing rates of the quadriceps and hamstring, and delayed spinal reflexes after a 
fatiguing protocol that led to a 50% decrease in work performed on the dynamometer.   
The precise physiologic mechanisms behind the fatigue-mediated alterations in 
neuromuscular control of the knee have yet to be determined.  It has been hypothesized that 
quadriceps fatigue decreases neuromuscular control of the knee joint by altering knee joint 
proprioception.58   Several studies have demonstrated that knee proprioception is less accurate in 
patients with knee OA versus control subjects.51,55,63,72,107  These studies have provided strong 
evidence that arthritic changes within the joint reduce the activity of the mechanoreceptors and 
subsequently diminish the joint proprioception.  Furthermore, several reports have demonstrated 
that muscle spindle and Golgi tendon organ activity may decrease with muscle fatigue, which in 
turn leads to decreased proprioception.77,84  The combined effects of knee OA and quadriceps 
fatigue on knee proprioception could potentially affect neuromuscular control of the knee and 
significantly decrease postural stability and lead to a staggering gait.  As a consequence this will 
impair mobility and performance of ADL in individuals with knee OA, leading to decreased 
patient's confidence and increased anxiety of falling.  Manipulating the difficulty of the postural 
control and keeping a smooth gait may significantly contribute to sensation of generalized 
fatigue.  By failing to sustain the required muscle force, the quadriceps fatigue may limit the time 
a person can stand, the distance a person can ambulate, or the number of stairs a person can 
ascend or descend.  Therefore, it may play a major role in the reduced functional performance 
and fatigue experienced by individuals with knee OA.   
Thus, quadriceps fatigue is another important finding in individuals with knee OA.  
Individuals with knee OA exhibited greater quadriceps fatigue than individuals without knee 
OA.  Quadriceps fatigue may decrease the neuromuscular control of the knee joint, which in turn 
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impairs the postural stability.  It is postulated that individuals with knee OA exhibit increased 
muscle fatigue which decreases their postural stability and put them at a risk of falling. 
Managing postural stability during performance of ADL could be an energy draining task for an 
elderly individual with knee OA. 
 
 
2.7.4 Cardiorespiratory Endurance  
 
2.7.4.1 Definition 
Cardiorespiratory endurance is defined as the ability to perform moderate to high 
intensity exercise using large muscle groups for an extended time period.4  Performance of such 
exercise depends on the functional state of the respiratory and cardiovascular systems.  The 
single best measure of cardiorespiratory endurance is maximal oxygen uptake (VO2 max) or 
aerobic capacity, which is the ability of these systems to supply oxygen to the working muscles 
in a manner that permits continuous exercise, or physical activities. 
2.7.4.2 Cardiorespiratory Endurance in Knee Osteoarthritis  
Knee OA restricts physical activity both directly and indirectly.  Pain, stiffness, fear of 
doing harm, and complying with incorrect beliefs to avoid strenuous and weight-bearing 
activities, encourage a sedentary lifestyle.  It has been reported that the presence of knee OA 
contributes substantially to functional limitations in performance of functional weight bearing 
tasks such as walking, stairclimbing, housekeeping, and carrying bundles.54.  Inactivity and 
subsequent decreased cardiorespiratory endurance, superimposed on the numerous impairments 
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associated with knee OA play a significant role in patient’s overall functional status and quality 
of life.  Decreased cardiorespiratory endurance in this population can be great burden and could 
obviously accelerate functional decline.96  Previous studies have demonstrated that individuals 
with knee OA have low aerobic capacity44,91  and significantly lower than age-and sex-matched 
controls.96  In the study by Minor et al91, 80 volunteers with symptomatic OA in weight-bearing 
joints were assessed using a maximal symptom-limited graded exercise tolerance test as per the 
Naughton treadmill protocol.  They found that VO2 max scores of patients with OA (mean age 64 
yrs) to be 15.3 ml/kg/min.  This value is approximately 20% lower than values in healthy older 
adults.8 
In further support of the findings, Philbin et al96 assessed VO2 max in 19 patients with 
knee OA (mean age 68 yrs) using a maximal symptom-limited graded exercise tolerance test 
utilizing a bicycle ergometer.  They found that patients with knee OA had significantly lower 
VO2 max mean scores compared to age-and sex-matched controls (knee OA 12.8 ± 3.7 versus 
controls 17.6 ± 5.2  ml/kg/min,  p <0.0005).   
VO2 max can be also expressed as the metabolic equivalent (MET) which is ratio of the 
metabolic rate of the average person while seated and resting, to the metabolic rate of a particular 
person while performing some task.  Resting metabolic rate (1 MET) requires 3.5 milliliters of 
oxygen per kilogram of body weight per minute.2  In a study by Ettinger et al44 it was reported 
that a high proportion of older people with knee OA have a VO2 max of 3-4 METS as measured 
by a symptom limited treadmill test.  It is equivalent to energy expenditure at moderate walking 
or doing multiple households tasks all at once with a moderate effort.2 Thus, the anaerobic 
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threshold may be reached in course of daily activities, causing fatigue and limited physical 
activities.  
2.7.4.3 Cardiorespiratory Endurance and Self-Reported Fatigue 
 The relationship between cardiorespiratory endurance and fatigue in individuals with 
knee OA has not been reported.  This may be due to the paucity of information about fatigue in 
individuals with knee OA.  In our clinic, patients with knee OA often report fatigue when they 
attempt to perform activities of daily living that require them to stand for a long period of time or 
to perform simple activities such as walking.  Stairs climbing was ranked by individuals with 
knee OA as the most common cause of pain and fatigue.  While this can be partially explained 
by the relationship of fatigue to pain, muscular dysfunction and decreased aerobic capacity 
ascribed to inactivity may also play important roles.  Aerobic capacity is an important 
component of overall health status, since it indicates the capacity to perform routine activities of 
daily living, required occupational tasks, and recreational endeavors, thus quality of life. It is 
expected that decrease aerobic capacity and muscular dysfunction will preclude individuals with 
knee OA from continuing their activities of daily living and it will be manifested as subjective 
sensation of fatigue.  
2.7.4.4 Estimation of VO2 max   (Aerobic Capacity) 
One of the most widely used submaximal exercise tests is the Astrand-Ryhming 
submaximal cycle ergometer test.7  This test was designed to predict VO2 max based upon the 
steady-state heart rate of a person exercising at one submaximal workload for 6 minutes.  A 
nomogram is used to estimate VO2 max based on the linear relationship between the heart rate 
and the VO2 max.  Because maximal heart rate decreases with age, and the data were collected 
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on young subjects ages 18-30 yrs, Astrand5 established age correction factors to multiply the 
estimated VO2 max values taken from the nomogram in order to correct for the lower maximal 
heart rate.  Astrand and Rodahl6 reported that the VO2 max estimated from the nomogram after 
correction for age underestimate the directly measured VO2 max when the value was low, but 
overestimate the value for well-trained athletes who have a high VO2 max.     
Siconolfi et al108 developed a modification of the Astrand-Ryhming protocol which 
accurately estimates VO2 max and is safe and suitable for assessing the cardiorespiratory 
endurance status of inactive people 20 to 70 years of age.  This protocol was adapted in this 
study for two reasons; 1) the procedure was validated on men and women of ages 20 to 70 years 
and 2) put the subjects under less stress by requiring that a heart rate of only 70% of age-
predicted maximal heart rate be achieved as described in chapter III.  It is deemed appropriate for 
the knee OA population because of the aforementioned reasons.     
The precedent section highlighted the relationship between knee OA and decreased 
aerobic capacity.  Inactivity and subsequent decreased aerobic capacity, superimposed on the 
numerous impairments associated with knee OA play a significant role in patient’s overall 
functional status and quality of life.  Decreased aerobic capacity in this population can be a great 
burden and could obviously accelerate functional decline.  An association between decreased 
aerobic capacity and self-reported fatigue in individuals with knee OA was presumed.  It is 
hypothesized that decreased aerobic capacity will preclude individuals with knee OA from 
continuing their activities of daily living and it will be manifested as subjective sensation of 
fatigue.  Thus, the anaerobic threshold may be reached in course of daily activities, causing 
fatigue and limited physical activities. 
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2.8 Summary 
In summary, fatigue is a complex phenomenon that may be affected by other frequently 
occurring problems in knee OA. It appears that little is known about the degree of fatigue 
severity in knee OA. It also appears that nothing is known about how well relevant muscle 
dysfunction, such as quadriceps fatigue and cardiorespiratory endurance are related to the 
subjective experience of fatigue in individuals with knee OA, above and beyond important 
demographic, physiological and psychosocial variables.  As a result of the limited research to 
date, which focuses primarily on the degree of fatigue severity and its relationships to other 
frequently occurring problems in knee OA, there was a need for a well designed study to 
explicate these complex interrelationships.  
2.9 Assumptions 
There are several assumptions in this study.  One assumption is that individuals with knee 
OA experience fatigue indirectly as a result of the disease process.  Another assumption is that 
individuals with knee OA are able to quantify and qualify their fatigue.  Demographic, 
physiological, and psychosocial variables are assumed to influence the experience of fatigue.  
2.10 Research Questions  
 The following research questions were addressed in this study: 
1. What is the magnitude and dimensions of self-reported fatigue in individuals with 
knee OA compared to others without knee OA?   
2. What is the influence of the quadriceps fatigue on self-reported fatigue in 
individuals with knee OA, while accounting for potential confounders such as 
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age, sex, pain, depression, and anxiety? 
3. What is the influence of the cardiorespiratory endurance on self-reported fatigue 
in individuals with knee OA, while accounting for potential confounders such as 
age, sex, pain, depression, and anxiety? 
 
2.11 Hypotheses  
Hypotheses for this study included the following:   
 
1. Individuals with knee OA would report significantly higher fatigue scores 
than those individuals who do not have knee OA and similar levels of 
fatigue as individuals with rheumatoid arthritis. 
2. When controlling for age, sex, pain, depression, and anxiety, individuals 
who have less quadriceps fatigue would report significantly lower fatigue 
scores than individuals who have more quadriceps fatigue.  In other 
words, quadriceps fatigue is a significant predictor of self-reported fatigue 
after controlling for age, sex, pain, depression, and anxiety.   
3. When controlling for age, sex, pain, depression, and anxiety, individuals 
who have better cardiorespiratory endurance would report significantly 
lower fatigue scores than individuals who have poor cardiorespiratory 
endurance.  In other words, cardiorespiratory endurance quadriceps fatigue 
is a significant predictor of self-reported fatigue after controlling for age, 
sex, pain, depression, and anxiety.   
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3 METHODOLOGY 
3.1 Introduction 
This chapter focuses on the methodology used in this study of fatigue in older adults with 
knee OA.  The outline for this chapter includes a description of the research design, subjects, 
measurement procedures, including psychometric properties of each procedure and procedures 
for statistical analysis.   
3.2 Research Design 
This descriptive study used a one group cross-sectional, correlational design to describe 
the prevalence and impact of fatigue and the role of factors that contribute to fatigue in knee OA.  
Descriptive and multiple regression analyses were conducted on data gathered from self-reported 
measures of pain and health-related quality of life and performance-based measures of function 
on a sample of patients with knee OA.  Self-reported measures collected in this study included 
demographic information, fatigue severity, pain intensity, depression, and anxiety.  Performance-
based measures collected in this study included quadriceps maximum voluntary isometric 
contraction (MVIC) torque output, cardiorespiratory endurance, and quadriceps fatigue.    
3.3 Study Sample 
3.3.1 Recruitment 
Subjects were recruited from physician’s offices of the University of Pittsburgh Medical 
Center (UPMC) Arthritis Network, the UPMC Arthritis Network Registry and from the physical 
therapy clinic at the UPMC Health System’s Center for Sports Medicine.  Potential subjects were 
informed of the study by their care providers (i.e., the physician for those subjects identified 
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through the UPMC Arthritis Network or the physical therapist for those patients identified 
through physical therapy clinic).  Permission to contact the subjects was obtained prior to 
making contact with the subjects.  Once potential subjects had granted permission to be 
contacted, the purpose of the study and the procedures that were to be utilized were described to 
them.  Additionally, subjects who participated in previously approved IRB studies related to 
knee OA conducted by our investigative team who verbally indicated to us that they would be 
willing to participate in future studies were also notified of the present study by letter and were 
asked to return a postcard (or telephone call) if they would like to participate in this study 
(Appendix A). 
When an individual agreed to participate in the study, the individual’s physician was 
contacted to ensure that there were no contra-indications to the individual’s participation in this 
study.  To accomplish this, a form was mailed or transmitted by fax to the physician.  The form 
included the subject’s name and explained the purpose of the study and the type of activities that 
the subject would be required to perform to participate in the study.  The subject’s physician was 
asked to indicate his/her approval for the subject to participate in this study, sign the form, and 
mail it back to the principal investigator.  Once permission from the individual’s physician had 
been granted, the individual was scheduled for the testing procedures (Appendix B).  All subjects 
signed an informed consent form approved by the University of Pittsburgh Institutional Review 
Board prior to participation in the study.   
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3.3.2 Inclusion Criteria 
Subjects included 44 individuals (33 females and 11 males) who had been diagnosed by 
their physician with knee OA involving the tibiofemoral and/or patellofemoral compartments.  
Subjects were included in the study if they were 45 years of age or older, met the 1986 American 
College of Rheumatology (ACR) clinical and radiographic criteria for knee osteoarthritis3, and 
had grade II or greater Kellgren and Lawrence radiographic changes.68  The 1986 ACR criteria 
for diagnosis of knee osteoarthritis includes knee pain with osteophytes and at least one of the 
following: age greater than or equal to 50 years, morning stiffness less than 30 minutes, or 
crepitus with active motion of the knee, such as when squatting while weightbearing.  
 
3.3.3 Exclusion Criteria 
Subjects were excluded from the study if they: 1) had limitations in knee motion that 
prevented them from comfortably positioning their knee for the quadriceps strength and fatigue 
tests (i.e. they have less than 70° of flexion); 2) had undergone total knee arthroplasty; 3) 
exhibited uncontrolled hypertension (i.e., systolic blood pressure greater than 140 mm Hg or 
diastolic blood pressure greater than 90 mm Hg); 4) had a history of cardiovascular disease; 5) 
had a history of patellar or quadriceps tendon rupture; 6) had a history of patellar fracture; 7) had 
any surgical procedures involving the patella, quadriceps tendon or patellar tendon or 8) had a 
steroid injection of the patellar or quadriceps tendons (Appendix C).  
Subject demographic information is provided in Table 1. 
3.4 Data Collection Methods 
All subjects participated in two testing sessions.  During the first session, individuals 
completed a demographic information questionnaire and self-reported measures of fatigue, pain, 
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depression, and anxiety.  A burst superimposition maximum isometric quadriceps torque test was 
performed to determine the quadriceps MVIC torque output that was used in the quadriceps 
fatigue test during the second session.  Individuals also performed a series of 10 submaximal 
isometric contractions of the quadriceps at 50% of MVIC torque to become familiar with the 
effort that will be required during the quadriceps fatigue test.  During the first testing session, 
subjects also performed a submaximal cycle ergometer test to estimate VO2 max as a measure of 
cardiorespiratory endurance.  Within one week after completing the first testing session, 
individuals were scheduled to come back again for a second testing session.  During the second 
testing session, the quadriceps fatigue test was performed on the same leg that was tested during 
the burst superimposition test. 
 
3.4.1 Self-Reported Measures 
3.4.1.1 Demographic Information 
Demographic data collected in this study included age, sex, height, weight, ethnicity, 
marital status, education level, employment status, past medical history and disease duration 
(Appendix D).
 
3.4.1.2 Multidimensional Assessment of Fatigue 
The Multidimensional Assessment of Fatigue (MAF) scale is a self-administered measure 
that contains 16 items and measures five dimensions of fatigue: degree (item 1), severity (item 
2), distress (item 3), degree of interference with activities of daily living (items 4-14), and timing 
(items 15-16)12 (Appendix E).  The MAF was scored according to the instructions from the MAF 
home page and through personal communication with the author of the instrument.12  Fourteen 
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items contain 10-point numerical rating scales (items 1-14) and two items have multiple-choice 
responses (items 15-16).  The 10-point numerical rating scale ranges from 1(not at all) to 10 (a 
great deal). Respondents are asked to reflect on fatigue patterns for the past week.  Scoring the 
MAF results in the Global Fatigue Index (GFI), a composite score of five dimensions of fatigue 
(degree, severity, distress, impact, and timing).  If the respondent reported no fatigue (item 1), a 
zero was assigned to all remaining items (2-16). Respondents, who do not do certain activities 
for reasons other than fatigue, are instructed to check a box to the left of each activity item and 
no score was assigned to this item.  For all respondents, item 15 which ask about frequency of 
fatigue was converted from 1-4 to 2.5-10 by multiplying responses by 2.5 for this item.  This 
conversion then allowed the items measuring degree of fatigue (item 1), severity of fatigue (item 
2), distress of fatigue (item 3), the average of impact on ADL items (items 4-14), and the newly 
scored frequency of fatigue item (item 15) to be summed to create the GFI.  The index score can 
range from 1 to 50 with 1 representing no fatigue and 50 representing extreme fatigue.    
Psychometric properties of the MAF were tested with 51 respondents with RA and 26 
age-and sex-matched controls.12  Cronbach's alpha was computed for the MAF to determine 
internal consistency and was found to be .93.  In this study, Cronbach’s alpha of the MAF was 
.92 for respondents with knee OA.  Evidence for validity was provided by a relatively high 
positive correlation with a concurrent measure of fatigue (POMS fatigue subscale, r=.84, p<.01) 
and a relatively strong negative correlation with a concurrent measure of vigor (POMS vigor 
subscale, r=-.62, p<.01).12 
The MAF scale is a good choice when selecting an instrument to measure fatigue in 
chronic illness as it is: easy to administer and score, relatively short in length (it takes less than 
five minutes to complete) and assesses the subjective aspects of fatigue including degree, 
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severity, distress, impact, and timing.  The questionnaire allows patients to omit activity items 
that do not apply, thus making it a more accurate assessment of the impact of fatigue on ADL.  
To yield reliable and valid responses, instructions are included on page one of the three-page 
instrument.  The instructions read: "These questions are about fatigue and the effect of fatigue on 
your activities during the past week".  If no fatigue is reported (i.e., respondents answer item 1 
by indicating they have not had any fatigue in the past week) then they are instructed to stop.  
The reason to stop is because items 2-16 are only applicable if the respondent had fatigue in the 
past week.  So as to assure variability in the outcome variable of fatigue, respondents who report 
no fatigue are assigned a zero score for items 2-16 and kept in the analysis.  
 
3.4.1.3 Pain 
 Pain was assessed using the pain subscale of the Western Ontario and McMaster 
Universities (WOMAC) Osteoarthritis Index11  The WOMAC is a widely used disease-specific, 
self-report measure of pain, stiffness, and physical function in individuals with OA of the hip or 
the knee.  The WOMAC consists of 5 questions about pain, 2 about stiffness and 17 about degree 
of difficulty in accomplishing daily living activities. The responses to the items are in the form of 
a 5-point Likert scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = extreme. The 
subscales are summed to maximum scores of 20, 8, and 68, respectively.  There is also an overall 
osteoarthritis index score, which is calculated by summing the scores of the 3 subscales.  The 
psychometric properties of the WOMAC score have been established. 11  Internal consistency 
(Cronbach’s alpha) of the WOMAC was found to be 0.86, .90 and .95 for the pain, stiffness and 
physical function subscales respectively.  Based on comparison with Lequesne Index scores, 
evidence for convergent construct validity of the WOMAC subscales was demonstrated by 
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Pearson correlation coefficients of 0.57, .35, and .55 for the WOMAC pain, stiffness, and 
physical function subscales respectively.  Evidence for divergent construct validity, based on 
comparison of WOMAC subscales with Bradburn Index of Well Being scores, was demonstrated 
by non-significant Pearson correlation coefficients of .15, -.09, and .24 for the WOMAC pain, 
stiffness, physical function subscales respectively.  The questionnaire is self-administered and 
takes 5 minutes to complete.  
 
3.4.1.4 Depression 
Depression was assessed using the Center for Epidemiologic Studies Depression Scale 
(CES-D)99.  The CES-D is a 20-item self-report measure that includes questions that pertain to a 
wide range of depressive symptoms.  Respondents are asked to rate the frequency of occurrence 
of each symptom in the past week on a 4-point Likert scale, which ranges from, 0 = rarely or 
none of the time (less than 1 day) to 3 = most or all of the time (5-7 days).  After reverse-scoring 
of items that are indicative of positive mood status (items 4, 8, 12, and 16), responses to the 20 
items are summed to obtain a total scale score.  The potential range of scores is from 0-60; 
higher scores indicate greater depression.  A score of 16 or greater typically is employed as a cut-
off that indicates clinical depression.19   
The CES-D has been used in numerous studies involving the psychiatric populations119 as 
well as older adult general populations80 and arthritis populations17 and has generally been found 
to have excellent psychometric properties.  Cronbach's alpha coefficient of 0.91 has been 
reported in the arthritis populations.  Convergent construct validity is evidenced by a positive 
correlation of 0.81 with AIMS depression subscale and divergent validity is evidenced by 
negative correlations of -0.59 to -0.80 with Rosenberg Self-Esteem Scale, Satisfaction With Life 
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scale, and General Positive Affect subscale from the 18-item Mental Health Inventory.17  Some 
arthritis researchers are concerned that four items on this scale might be measuring disease 
symptoms rather than depression, and thus depression scores might be inflated among people 
with arthritis.  These items include; "I felt that everything I did was an effort," "I felt hopeful 
about the future," "My sleep was restless," and "I could not get going." However, study has 
found that results are the same when scores were analyzed with or without these four items in a 
sample of arthritis patients.17  The CES-D is an easy to complete self-administered questionnaire 
that has demonstrated its usefulness as a screening tool for detecting depressive symptoms 
among community-residing elderly adults and arthritic patients17,80  
 
3.4.1.5 Anxiety  
Anxiety was assessed using the Beck Anxiety Inventory Scale (BAI).  The BAI is a 21-
item self-report questionnaire measuring common symptoms of clinical anxiety, such as 
nervousness and fear of losing control10.  Respondents indicate the degree to which they were 
bothered by each symptom during the past week.  Each symptom is rated on a 4-point Likert 
scale ranging from 0 (not at all) to 3 (severely, I could barely stand it), and the total score ranges 
from 0 to 63, with higher scores corresponding to higher levels of anxiety.   The BAI has 
excellent internal consistency with psychiatric outpatients.10   Beck, et al10 reported a Cronbach's 
alpha of 0.92.  The BAI discriminated anxious from non-anxious diagnostic groups.  In addition, 
the BAI was moderately correlated with the clinician-administered Hamilton Rating Scale for 
Anxiety (r =.56), and mildly correlated with Hamilton Rating Scale for Anxiety (r = .25)10 
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3.4.2 Performance-Based Measures 
3.4.2.1 Burst Superimposition Maximum Isometric Quadriceps Torque Test: 
To perform this test, subjects were seated on an isokinetic dynamometer (Biodex System 
3 Pro, Shirley, NY) and secured to the seat by torso, pelvic and thigh straps to minimize 
movements of these segments. The knee that the subject reported as being the most symptomatic 
knee with regard to pain and functional limitation was selected for testing.  The center of rotation 
of the dynamometer was aligned with the lateral femoral epicondyle.  The knee being tested was 
positioned at 60° of flexion with the force arm-pad attached just above the ankle by means of a 
Velcro strap.  A Grass Model S8800 electrical stimulator with a Grass Model SIU8T stimulus 
isolation unit (Grass Instrument Company, Braintree, MA) was used to deliver the electrical 
stimulation.  The skin in the area of electrode placement sites over the anterior thigh was 
cleansed with rubbing alcohol, then two 6.9 cm by 12.7 cm self-adhesive electrodes (Dura-Stick, 
Chattanooga Group, Hixson, TN) were placed on the quadriceps muscle so that an electrical 
stimulus could be applied during the testing procedure.  The cathode was placed proximally over 
the muscle belly of the vastus lateralis and the anode was placed distally over the muscle belly of 
the vastus medialis.   
Once the patient was prepared for testing, we employed a process of potentiating the 
quadriceps muscle to maximize the subject’s ability to produce maximum torque output.109   In 
addition, this process familiarized the subjects with the maximum voluntary isometric torque test 
procedure as well as the electrical stimulus to be used during testing which also minimized the 
potential for learning effects on the test results.  The first step in this process was to instruct the 
subjects to practice producing voluntary isometric quadriceps contractions against the arm of the 
dynamometer at 50%, 75% and 100% of their maximum voluntary effort.  Following the practice 
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trials, three successive trains of electrical stimulus (pulse duration= 0.6 msec, pulse interval=10 
msec, train duration=100 msec), separated by 30 seconds, were applied to the subject’s resting 
quadriceps muscle at amplitudes of 40 volts, 60 volts, and 100 volts respectively.   
Following the potentiating process, the burst superimposition maximum isometric 
quadriceps torque test was performed.  Subjects were instructed to exert as much force as 
possible while extending the knee against the force-sensing arm of the dynamometer.  During the 
contraction, a train of electrical stimuli (amplitude = 100 volts, pulse duration=0.6 msec, pulse 
interval=10 msec, train duration=100 msec) was applied to determine the extent of QAF.  A 
torque target line was displayed on the computer monitor to provide subjects with visual 
feedback in an effort to maximize their ability to produce maximum torque during the test.  The 
torque target was placed at a force level slightly greater than the peak torque produced during the 
practice MVIC.  If subjects exceeded this torque target during a given trial, the target was reset at 
a higher level on the next trial.  The test was repeated 4 times.  The MVIC and superimposed 
electrical stimulation (SES) torque outputs were recorded (Appendix F).  The highest MVIC 
achieved during the 4 trials was used for the analyses described below.  Experience over the last 
three years has indicated that individuals ranging in age from 18 to 82 have been able to tolerate 
this test without difficulty.  This procedure has been shown to yield reliable quadriceps muscle 
torque measurements.  Test-retest reliability of the procedure on healthy subjects (no knee 
impairments) demonstrated an ICC of 0.98.111  
 
3.4.2.2 Submaximal Cycle Ergometer Test 
A modified Astrand-Ryhming submaximal cycle ergometer test was used to estimate 
VO2 max.108  To eliminate any potential factors that might affect the performance of the test 
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subjects were requested not to eat, smoke, or exercise for 2 hours prior testing. To perform this 
test subjects rode a stationary ergometer (Monarch, Ergomedic 818E).  The bike seat was 
adjusted so that the subject’s knees were almost completely extended when the foot was at the 
bottom of the pedaling cycle.  The subject started pedaling at a rate of 50 revolutions per minute 
(rpm) against an initial workload of 25 W.  The pedaling rate was kept constant during the course 
of the test using the bike’s built-in electronic meter.  During the test, the heart rate was 
monitored every minute using a chest strap heart rate monitor (Polar Electro, Inc Woodbury, 
NY).  The workload was increased by 25 W every two minutes until the subject achieved a target 
heart rate (i.e., 70% of age-predicted maximal heart rate).  After attaining this threshold, the 
subject continued exercising at the same workload for at least two more minutes until a steady-
state heart rate was achieved.  Steady-state heart was concluded to be present when consecutive 
(1 min apart) heart rates differed by ≤ 5 bpm.  Figure 1 shows a schematic representation of the 
protocol.  
To ensure the subject’s safety during this submaximal cycle ergometer test, blood 
pressure was monitored every 3 minutes during the test.  The normal blood pressure response 
during exercise includes a progressive increase in systolic blood pressure with no change or a 
slight decrease in diastolic blood pressure.  An abnormal blood pressure response is one in which 
systolic blood pressure fails to increase with increased exercise intensity or an excessive increase 
in either systolic or diastolic blood pressure.  The test was terminated if an abnormal blood 
pressure response to exercise occurred.  The submaximal exercise test was terminated if systolic 
blood pressure failed to increase with increased exercise intensity or if systolic blood pressure 
exceeded 170 mm Hg or diastolic blood pressure exceeded 110 mm Hg or if the heart rate 
exceeded 85% of the subject’s age-predicted maximum value.   
 47
The VO2 max was estimated from the table of VO2 max values derived from the Astrand-
Ryhming nomogram6,7  using the mean steady-state heart rate and the final workload.  The mean 
steady-state heart rate is the average of the last two heart rate readings (Appendix G)  The 
estimated VO2 max obtained from the table was corrected for age with sex-specific regression 
equations derived by Siconolfi et al108. The age-corrected estimated VO2 max value was then 
compared to norms of VO2 max relative to age and sex to determine the fitness level for each 
subject.52 
The original Astrand-Ryhming submaximal cycle ergometer test was designed to 
estimate VO2 max based on the steady-state heart rate of a person exercising at a constant 
submaximal workload for 6 minutes and was validated on young subjects ages 18-30 years.7  
However, the modified Astrand-Ryhming cycle ergometer test was selected as a submaximal 
measure of VO2 max because the procedure has been validated on men and women 20 to 70 
years of age and it only requires subjects to reach 70% of their age-predicted maximum heart rate 
value.108        
Concurrent validity of the test was established by comparing the estimated VO2 max 
score using the regression equations to the VO2 max score measured directly using a 
pneumotachograph and gas analyzers during a maximal cycle ergometer test.108  No significant 
difference was found between the measured and estimated VO2 max and they were highly 
correlated to each other (r = .94).  The standard error in predicting the directly measured VO2 
max was ± .248 L/min.   
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3.4.2.3 Quadriceps Fatigue Test 
To perform the quadriceps fatigue test, subjects were seated on the dynamometer with the 
dynamometer position settings identical to those used during the burst superimposition 
maximum isometric quadriceps torque test.  Before initiating the quadriceps fatigue test in the 
second session, the quadriceps was potentiated in the same manner as the first session as 
described earlier.  Because the SES isometric torque output determined by the burst 
superimposition test is the best estimate of peak isometric quadriceps torque output, it was used 
to establish the target torque level that was displayed on the computer monitor during the 
quadriceps fatigue test.  The torque target value was equal to 50% of the SES isometric torque 
output.  During the fatigue test, subjects performed repeated submaximal contractions equal to 
50% of their SES isometric torque output for 6 seconds followed by a 4-second rest period (duty 
cycle 60%).  The contractions were continued until the subject could no longer generate that 
torque target for 3 successive contractions (i.e., exhaustion).  During the sixth contraction and 
every minute thereafter, subjects were instructed to push with a maximum effort and the train of 
electrical stimuli (amplitude = 100 volts, pulse duration=0.6 msec, pulse interval=10 msec, train 
duration=100 msec) was superimposed upon the maximal effort quadriceps contraction (Figure 
2)
Standardized instructions were provided during the testing procedure (i.e. start pushing, 
stop pushing) to avoid undue influence of the tester on the individual’s effort.  Individuals were 
free to stop the test at any point.  Blood pressure and heart rate were monitored every three 
minutes during the test.  The quadriceps fatigue test was terminated if systolic blood pressure 
exceeded 170 mm Hg, or if diastolic blood pressure exceeded 110 mm Hg or if heart rate 
exceeded 85% of age predicted maximum heart rate.  The MVIC and SES torques were recorded 
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(Appendix H).  Quadriceps fatigue was measured as the rate of decline of the MVIC torque 
output over the course of the test.  Good test-retest reliability for the quadriceps fatigue test was 
determined in healthy individuals (ICC = 0.89, 95% CI = 0.75 to 0.95).  The SEM value for the 
test was 0.77 percent of the maximum electrically elicited isometric force output per minute.  
The minimum detectable change (MDC) based on the SEM for repeated measurements was 2.13 
percent of the maximum electrically elicited isometric force output per minute. 
 
3.5 Data Analysis 
The Statistical Package for the Social Sciences (SPSS for Windows, version 11.01, 
Chicago, IL) was used to calculate descriptive statistics for the sample and to perform the 
inferential statistical analyses used in this study.   
Descriptive statistics, including frequency counts for categorical variables and measures of 
central tendency and dispersion for continuous variables were first calculated to summarize the 
data.  Means, standard deviations, and ranges were used to describe the total score on GFI and 
the score on the five dimensions of fatigue: degree, severity, distress, impact on activities 
of daily living, and timing.  To measure quadriceps fatigue, simple linear regression was 
performed to determine the rates of decline (i.e. the slope parameters) for the MVIC, and SES 
torque outputs.  To determine the mechanisms of quadriceps fatigue, paired samples t-tests were 
performed to detect difference among the rates of decline in MVIC and SES torques.  If the rates 
of decline were not statistically different, then we concluded that fatigue was peripheral.  In 
contrast, if the rates of decline were statistically different (i.e., the MVIC torque declined quicker 
than the SES torque) then we concluded that fatigue was central.  Pearson correlation 
coefficients were calculated to describe the relationships between age, sex, pain, depression, 
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anxiety, quadriceps fatigue, cardiorespiratory endurance, and fatigue.  Statistical significance for 
all tests was set at p< 0.05.  All data were screened to ensure they met the assumptions for the 
inferential statistical analyses described below. 
3.5.1 Research Question 1 
What is the magnitude and dimensions of self-reported fatigue in individuals with knee 
OA compared to healthy control subjects and individuals with rheumatoid arthritis?   
 
3.5.1.1 Hypothesis 1 
It was hypothesized that individuals with knee OA would report significantly higher 
fatigue scores than those individuals who do not have knee OA and similar levels of fatigue as 
individuals with rheumatoid arthritis. 
 
3.5.1.2 Analysis Hypothesis 1  
These hypotheses were tested with independent samples t-test.  The magnitude and 
dimensions of self-reported fatigue in this study were compared to those of controls and patients 
with RA obtained from a previous study that used the same fatigue scale (i.e., MAF) that was 
used in this study to measure fatigue.12 
 
3.5.2 Research Question 2 
What is the influence of the quadriceps fatigue on self-reported fatigue in individuals 
with knee OA, while accounting for potential confounders such as age, sex, pain, depression, and 
anxiety? 
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3.5.2.1 Hypothesis 2 
It was hypothesized that when controlling for age, sex, pain, depression, and anxiety, 
individuals who have less quadriceps fatigue would report significantly lower fatigue scores than 
individuals who have more quadriceps fatigue.  In other words, quadriceps fatigue is a significant 
predictor of self-reported fatigue after controlling for age, sex, pain, depression, and anxiety.   
 
3.5.2.2 Analysis Hypothesis 2  
To examine this hypothesis, a hierarchical multiple regression analysis was performed to 
determine the influence of quadriceps fatigue on the subject’s perception of fatigue in individuals 
with knee OA. The dependent variable for this analysis was the GFI total score.  In this analysis, 
the variables that were hypothesized to influence fatigue including age, sex, pain, depression, 
and anxiety were accounted for first.  This was accomplished by first entering these variables 
into the model in one block followed by quadriceps fatigue in the second block to determine how 
much additional variance (R2) in GFI was accounted for by quadriceps fatigue after controlling 
for age, sex, pain, depression, and anxiety. 
 
3.5.3 Research Question 3  
What is the influence of the cardiorespiratory endurance on self-reported fatigue in 
individuals with knee OA, while accounting for potential confounders such as age, sex, pain, 
depression, and anxiety? 
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3.5.3.1 Hypothesis 3    
It was hypothesized that when controlling for age, sex, pain, depression, and anxiety, 
individuals who have better cardiorespiratory endurance would report significantly lower fatigue 
scores than individuals who have poor cardiorespiratory endurance.  In other words, 
cardiorespiratory endurance is a significant predictor of self-reported fatigue after controlling for 
age, sex, pain, depression, and anxiety. 
 
3.5.3.2 Hypothesis Analysis 3    
 To examine this hypothesis, a hierarchical multiple regression analysis was performed to 
determine the influence of cardiorespiratory endurance on the subject’s perception of fatigue in 
individuals with knee OA. The dependent variable for this analysis was the GFI total score.  In 
this analysis, the variables that were hypothesized to influence fatigue including age, sex, pain, 
depression, and anxiety were accounted for first.  This was accomplished by first entering these 
variables into the model in one block followed by cardiorespiratory endurance in the second 
block to determine how much additional variance (R2) in GFI was accounted for by 
cardiorespiratory endurance after controlling for age, sex, pain, depression, and anxiety. 
 
3.5.4 Sample Size Estimation 
 The general multiple regression option in SamplePower, Release 1.20 (SPSS Inc., 
Chicago, IL) was used to estimate the sample size needed to achieve statistical power of at least 
80%.  Refer to Table 2  for parameters used to estimate this study sample size.  Based on the 
proposed analytical design to study age, sex, pain, depression, anxiety, cardiorespiratory 
endurance, and quadriceps fatigue variables as determinants of fatigue, the following 
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calculations were used to estimate the necessary sample size.  The six covariates used in this 
multiple regression analysis were age, sex, pain, depression, and anxiety.   In a previous study 
that investigated fatigue in RA patients, sex, pain, depression, and anxiety accounted for 49% of 
the variability in fatigue.64   A 10% increase in explained variability with the addition of either 
quadriceps fatigue or cardiorespiratory endurance was believed to be a clinically meaningful 
increase in explained variability of self-reported fatigue.  Given these assumptions, at least 40 
subjects were necessary to obtain 80% power for this study.     
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4 RESULTS 
4.1 Introduction 
This chapter presents the results of a study of fatigue in 44 older adults with knee OA. 
The outline for this chapter includes a description of the: 1) demographic characteristics of the 
sample; 2) magnitude of fatigue; 3) factors associated with fatigue; 4) relationships of age, sex, 
pain, depression, anxiety, quadriceps fatigue, and cardiorespiratory endurance with self-reported 
fatigue; and 5)  the results of the hypothesis tests described above.     
4.2 Demographic Characteristics  
Demographic characteristics of the sample are presented in Table 1.  The mean age of the 
sample was 65 years (SD=8.9, range 50-86).  There were 33 females (75%) and 11 males (25%).  
Slightly less than half of the sample (43.2%) had the symptoms of knee OA for 5 to 10 years.  
Over half of the sample (68.2%) was married and 18.2% was widowed.  The educational level of 
the sample was high.  All subjects had completed high school and 19 (43%) completed college.  
Twenty-five percent of the sample had post-graduate degree.  Less than half of the sample 
(38.6%) was retired, 29.5% were working full time regular duty, and only few (6.8%) were 
unable to work or were retired due to health status. Almost half (47.7%) of the sample was 
involved in a walking program and performing muscle stretching to help lessen their pain and 
stiffness from knee OA.  
  
 55
4.3 Magnitude of Fatigue 
The magnitude of fatigue in this sample of individuals with knee OA is described in 
Table 3.  In this sample, 41 (93.2%) respondents reported some degree of fatigue during the 
week before participation in this study.  The mean score on the GFI was 23.6 (SD = 10.4, range 
1-40).  Respondents reported a mean score of 5.3 ± 2.1 for the degree of fatigue, 4.6 ± 2.1 for the 
fatigue severity, and 4.1 ± 2.7 for the distress from fatigue.  For 25% of the sample, fatigue 
occurred every day.  More than half of the sample (59.1%) reported fatigue was unchanged 
during the course of a week, and most often fatigue affected walking (mean = 4.7, SD = 2.7), 
doing household chores (mean = 4.3, SD = 2.5), shopping (mean = 4.3, SD = 2.7), and exercise 
(mean =3.8, SD =2.4). Sex differences in reported fatigue were examined and are presented in 
(Table 4).   Women reported significantly higher fatigue scores in all dimensions than men (p < 
0.05).  
 
4.4 Description of Factors Associated with Fatigue  
Means, standard deviations, and observed ranges of the variables associated with self-
reported fatigue are shown in Table 5  .  With respect to the depressive symptoms, the mean 
score for the CES-D was 10.5 (SD = 8.4, range 0-39).  Ten (23%) of the respondents scored 16 
or above on CES-D indicating that they were possibly depressed as defined by Radloff in 1977.99   
During the quadriceps fatigue test, both the MVIC and SES torques gradually declined 
relative to their initial values (Figure 3)  Simple linear regression was used to calculate the rate 
of decline (i.e., the slope parameters) for the MVIC and SES torques for each subject. The mean 
rate of decline in MVIC torque, which is a measurement of quadriceps fatigue, was 7.1 %/min 
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(SD = 5.1, range 0.98 – 21.9).  The mean rate of decline in SES torque was 5.5 %/min (SD = 3.7, 
range 0.67 – 17.50).  The mean endurance time (i.e., exhaustion) for the quadriceps fatigue test 
was 7.39 ± 4.74 min (range, 2 to 23 min).  To determine the mechanisms of quadriceps fatigue, a 
paired samples t-test was performed to detect differences among the rates of decline in MVIC 
and SES torques at each subject’s endurance time (Figure 4).  The rates of decline were 
statistically different (p <.001). Therefore, it was concluded that fatigue was central in nature. 
Because the time to fatigue was different as shown in (Figure 5), the rates of decline in 
torques were compared at 2, 5, and 7 minutes of the fatigue task. The rates of decline in torques 
were compared at 2 minutes of the fatigue task because all the subjects were able to perform the 
test for at least 2 minutes, thus all subjects were included in this analysis.  The rate of decline in 
torques were also compared at 5 minutes of the fatigue task, which corresponded to the mode of 
time to fatigue and at 7 minutes of the fatigue task, which corresponded to the mean time to 
fatigue.  Significant differences were found between the rates of decline in torques when the 
calculations were based on 2, 5, or 7 minutes of the fatigue task (p <.05). Means and standard 
deviations of the rates of decline in torques at 2, 5, and 7 minutes of the fatigue task are 
presented in Table 6.  Thus, it was concluded that time to fatigue did not affect the conclusion 
that fatigue was central in nature.       
 
4.5 Relationships among Variables  
The direction, strength, and statistical significance of the bivariate correlations between 
fatigue and the independent variables of interest are listed in Table 7.  Fatigue was not 
significantly correlated with age (r = -.04, p = .81).  Sex was positively and significantly 
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correlated with self-reported fatigue (r = .52, p <.001).  Women had higher levels of fatigue than 
men.  Fatigue was positively and significantly associated with pain (r = .62, p < .001), depression 
(r = .47, p < .05), and anxiety (r = .54, p < .05), indicating that high levels of pain, depression, 
and anxiety were associated with greater fatigue.  Additionally, fatigue was negatively and 
significantly associated with cardiorespiratory endurance (r = -.55, p <.001), indicating that poor 
cardiorespiratory endurance was associated with greater fatigue.  However, fatigue was weakly 
and not significantly associated with quadriceps fatigue (r = .01, p = .71).  
 
4.6 Hypothesis Testing 
Hypothesis 1 stated that individuals with knee OA would report significantly higher 
fatigue scores than those individuals who do not have knee OA and similar levels of fatigue as 
individuals with rheumatoid arthritis. These hypotheses were tested with independent samples t-
tests.  The magnitude and dimensions of self-reported fatigue in this study were compared to 
those of controls and patients with RA obtained from a previous study that used the same fatigue 
scale (i.e., MAF) used in this study to measure fatigue.12 The control group included 46 
individuals (91% females) with a mean age of 42 years who had not been diagnosed with 
rheumatic disease.  The RA group included 51 patients (85% females) with a mean age of 43 
years who had been diagnosed by their physician with RA. Individuals with knee OA reported 
significantly higher fatigue than controls (Table 8)  and significantly lower fatigue than RA 
patients (Table 9).  (p < 0.05). 
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Hypothesis 2 stated that when controlling for age, sex, pain, depression, and anxiety, 
individuals who have less quadriceps fatigue would report significantly less fatigue compared to 
individuals who have more quadriceps fatigue.  A two-step hierarchical regression analysis was 
used to test this hypothesis.  The dependent variable for the model was the GFI.  The GFI is a 
composite score of the five dimensions of fatigue; degree, severity, distress, impact, and timing.  
Six independent variables were grouped into two sets.  Table 10 show the results of the 
hierarchical regression analysis to determine the influence of quadriceps fatigue on self-reported 
fatigue after controlling for age, sex, pain, depression, and anxiety.  The first set of variables 
entered into the model included age, sex, pain, depression, and anxiety.  The first step accounted 
for 55% of the variance of self-reported fatigue (F = 9.12, p < .001).  In the second step, 
quadriceps fatigue was entered into the model.  Addition of the quadriceps fatigue did not 
provide any additional explanation of the variability in fatigue.  Therefore, this hypothesis was 
not supported.  In other words, after controlling for age, sex, pain, depression, and anxiety, 
quadriceps fatigue did not have any influence on self-reported fatigue.  The standardized beta 
coefficients for the final model including quadriceps fatigue are reported in Table 11.  The 
strongest individual predictors of fatigue were sex and depression. 
         
Hypothesis 3 stated that when controlling for age, sex, pain, depression, and anxiety, 
individuals who have better cardiorespiratory endurance would report significantly lower fatigue 
scores than individuals who have poorer cardiorespiratory endurance.  A two-step hierarchical 
regression analysis was used to test this hypothesis.  The dependent variable for the model was 
the GFI.  Six independent variables were grouped into two sets.  Table 12 shows the results of 
the hierarchical regression analyses to determine the influence of cardiorespiratory endurance on 
 59
self-reported fatigue after controlling for age, sex, pain, depression, and anxiety. The first set of 
variables entered into the model were age, sex, pain, depression, and anxiety, which accounted 
for 61% of the variance in self-reported fatigue (F = 11.75, p < .001).  In the second step 
cardiorespiratory endurance was entered into the model, which did not explain any additional 
variation in self-reported fatigue.  Therefore, this hypothesis was not supported.  In other words, 
after controlling for age, sex, pain, depression, and anxiety, the addition of cardiorespiratory 
endurance did not have any influence on self-reported fatigue. The standardized beta coefficients 
for the final model including cardiorespiratory endurance are reported in Table 13.  The strongest 
individual predictors of fatigue were sex and depression.     
A stepwise regression analysis was performed to determine the “best” regression model 
for prediction of fatigue. The standardized beta coefficients and the statistical significance of 
each variable in the “best” model for prediction fatigue are reported in Table 14.   Pain, sex, and 
depression constituted the “best” model for prediction fatigue and accounted for 53% of variance 
in fatigue.       
 
4.7 Testing Assumptions of the Statistical Model 
 Tests were conducted to check for violations of the statistical assumptions.  Residual 
scatterplots were reviewed for outliers, homogeneity of variance, and linearity.  The correlation 
matrix was examined for multicolinearity. 
 Residual scatterplots showed no outliers, which are any data points greater than three 
standard deviations from the mean of the residuals.71  In reviewing the residual scatterplots, a 
check for homogeneity of variance revealed constant variability over the range of dependent 
values.  No heteroscedasticity was noted. 
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 Another assumption tested was that of linearity.  Residual scatterplots as a function of 
predicted value were examined for linearity and no evidence of curvilinear relationships was 
found.  Multicolinearity occurs when there are high intercorrelations among the independent 
variables.71  A correlation matrix of independent variables was generated as shown in Table 7.  
Correlations between variables ranged from .05 to .56 (ignoring directions).  Based on the 
magnitudes of these relationships it appears that multicolinearity was not a problem in this data 
set.  Based on these analyses, it appears that the assumptions of homogeneity of variance, 
linearity, and independence were met.     
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5 DISCUSSION 
5.1 Introduction   
This chapter includes an interpretation of study’s primary findings and a discussion of 
their significance.  There is also a discussion of the implications of the study for physical 
therapy, and recommendations for further research.   
The purposes of this study were threefold; 1) to describe the magnitude and dimensions 
of self-reported fatigue in individuals with knee OA, 2) to determine the influence the quadriceps 
fatigue on self-reported fatigue in individuals with knee OA, while accounting for potential 
confounders such as age, sex, pain, depression, and anxiety and 3) to determine the influence of 
the cardiorespiratory endurance on self-reported fatigue in individuals with knee OA, while 
accounting for potential confounders such as age, sex, pain, depression, and anxiety.  
  
5.1.1 Interpretation and Significance of Findings  
The sample consisted of 44 older adults (75% females) with a mean age of 65 years who 
had radiographically confirmed knee OA. The presence of fatigue was a significant problem in 
this study sample. Fatigue occurred every day, was consistently present during the course of the 
week, and affected activities of daily living.   
Bivariate correlations revealed that fatigue was significantly associated with sex (greater 
fatigue in females), pain, depression, and anxiety.  These factors that were associated with self-
reported fatigue in individuals with knee OA were also found to be associated with fatigue in 
individuals with a spectrum of rheumatic disesases.12,13,25,34,64,74,75,89,93,101,114,115,118,123 
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5.1.1.1 Magnitude of Self-Reported Fatigue   
Since no prior reports offer comparable detail on fatigue in OA, no direct comparison can 
be made.  However, the observation of fatigue in individuals with knee OA was compared to 
previous studies that addressed fatigue in RA patients and controls (no rheumatic disease) using 
the same fatigue scale.12  This comparison was based on the fact that both OA and RA are 
common joint diseases that have similar clinical manifestations such as pain, stiffness, and 
functional limitations.  Individuals with knee OA in this study reported significantly lower 
fatigue than RA patients but significantly higher fatigue than controls.  However these results 
must be interpreted carefully due to differences in the mean age between the studies.  The mean 
age of the knee OA group was 65 years, whereas the mean age of the RA group was 43 years and 
the mean age of the controls group was 42 years.  This may raise a question regarding the effect 
of age on fatigue.  Evidence showed that fatigue was not related to age in individuals with 
RA13,64 nor in individuals without rheumatic diseases.81  Consistent with the findings of other 
investigators13,64,81, we found that age was not related to fatigue (r = -.04, p =.81). 
 
5.1.1.2 Magnitude and Mechanisms of Quadriceps Fatigue   
To our knowledge, this quadriceps fatigue protocol has not been used to measure fatigue 
in individuals with knee OA prior to this study.  Therefore, it was not possible to compare the 
degree of quadriceps fatigue in this sample to comparable population.  However, this technique 
was used to investigate quadriceps fatigue in 9 individuals (mean age 29 years) diagnosed with 
FM.90  In contrast to our findings, the mean rate of decline in MVIC torque in individuals with 
FM was found to be 1.7 %/ min, while the mean rate of decline in MVIC torque in individuals 
with knee OA was found in this study to be 7.1 %/min.  This difference could be attributed to the 
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fact that fatigue exercise was performed at 30% of MVIC by young people with FM, while in the 
present study it was performed at 50% of MVIC on elderly people with knee OA.          
The significant difference between the rates of decline in MVIC and SES torques during 
quadriceps fatigue test in this study led to the conclusion that fatigue was central in nature. In 
contrast to our results, quadriceps fatigue in patients with FM was observed to be peripheral.  
This may be explained by the fact that OA is a joint disease whereas FM is a muscular disease.  
In the present study, quadriceps fatigue was central which may lead to the expectation that 
depression and anxiety would have contributed to the lack of motivation.  Data in this study did 
not support this conjecture.   
   
5.1.1.3 Influence of Quadriceps fatigue on Self-Reported Fatigue 
Self-reported fatigue was not significantly associated with quadriceps fatigue.  An 
attempt was made in this study to determine the influence of quadriceps fatigue on self-reported 
fatigue after controlling for age, sex, pain, depression, and anxiety.  This was accomplished by 
performing a hierarchical regression analysis.  The results revealed that quadriceps fatigue had 
no influence on self-reported fatigue above and beyond demographic, physiological, and 
psychosocial variables.  This can be explained by the lack of a bivariate association between 
quadriceps fatigue and self-reported fatigue.  As a result of this, the functional significance of 
quadriceps fatigue in knee OA must be questioned.                
The lack of association between quadriceps fatigue and self-reported fatigue may be due 
to differences in the method of measurement between the two variables.  Self-reported fatigue 
was reported by the patient as his/her perception of general fatigue, while quadriceps fatigue was 
a performance-based measure of local muscular fatigue.  Several investigators have 
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demonstrated that self-reported and performance-based measures of the same phenomenon are at 
most moderately related to each other indicating that they may measure different aspects of the 
same construct.33,43,100,103,104 In this study, self-reported fatigue reflected the individual’s 
perception of fatigue that may encompasses the whole body, whereas the quadriceps fatigue test 
examined the quadriceps muscle’s ability to sustain the required level of muscle force during an 
repeated isometric contractions of the quadriceps.    The lack of association between the two 
measures indicated that they measured different unrelated aspects of fatigue that we 
hypothesized would be related.  Our observations did no support this hypothesis.  Because 
quadriceps fatigue may limit the distance a person can ambulate, we evaluated the relationship 
between the single item on the MAF that queried the subject on the impact of fatigue on walking 
and the results of the quadriceps fatigue test.  If quadriceps fatigue is related to self-reported 
fatigue in any manner, we would expect that there would be a relationship between quadriceps 
fatigue and the item that was most directly related to function of the quadriceps muscle (i.e. 
impact of fatigue on walking).  The bivariate correlation between quadriceps fatigue and the 
subject’s self-report of the impact of fatigue on walking was .08 (p=.61).  Thus quadriceps 
fatigue does not appear to be in any way related to self-reported fatigue by subjects with knee 
OA.  
 
5.1.1.4 Functional Significance of Quadriceps fatigue 
Given the lack relationship between quadriceps fatigue and self-reported fatigue and the 
lack of any significant associations between quadriceps fatigue and any of the other variables as 
shown in Table 7 , we must question the functional significance of quadriceps fatigue in subjects 
with knee OA.  Quadriceps fatigue, when measured as the ability to maintain a maximal 
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isometric contraction for 90 seconds, has been found to be related to the time required to walk 50 
ft, but not to the degree of dependence, difficulty, or pain experienced during a variety of daily 
activities.48  The failure to demonstrate the functional significance of quadriceps fatigue, 
measured as the ability to maintain a maximal isometric contraction for 90 seconds, was thought 
to be due to the fact that most daily activities do not require a single maximal isometric 
contraction of the quadriceps and the demands of normal daily functional activities on muscles 
are more closely reproduced by repetitive, submaximal exercise. In our preliminary work, we 
developed a fatigue test that consisted of repeated submaximal quadriceps contractions at 50% of 
maximal effort (unpublished data).  Quadriceps fatigue was operationally defined as the number 
of contractions an individual could perform before he or she was no longer able to generate 50% 
of the MVIC quadriceps torque.  Using that procedure to measure quadriceps fatigue, we were 
unable to demonstrate a relationship between quadriceps fatigue and concurrent self-reported or 
performance-based measures of physical function.  Concurrent self-reported measures of 
physical function included the WOMAC physical function and total scores, the ADLS scale of 
the Knee Outcome Survey, and the physical components summary scores of the SF-36 and the 
performance-based measure of physical function consisted of the "get-up and go" test.     
To further the investigation of the effect of knee OA on quadriceps fatigue, in this study 
we defined quadriceps fatigue as a progressive decline of the maximum voluntary contraction 
over the course of time.  Based on this definition, quadriceps fatigue in this study was found to 
be negatively related to quadriceps muscle strength normalized to body mass index (BMI) (r = -
.35, p =.02), but not to the degree of difficulty (r = -.02, p = .93), or pain  
(r = -.05, p = .74) experienced during activities of daily living as measured by WOMAC physical 
function and pain subscales respectively.  In contrast, quadriceps muscle strength normalized to 
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BMI was negatively related to the degree of difficulty (r = -.39, p = .009), and pain (r = -.42, p = 
.005) experienced during activities of daily living, indicating that individuals with a strong 
quadriceps muscle relative to body mass index had less difficulty and pain during daily activities 
but had greater quadriceps fatigue.  This relationship between muscle strength and endurance can 
be explained by the age-related morphological adaptation of the human muscle.  Evidence 
indicates that with aging, human muscle tends to have a greater proportion of type I fibers 
(fatigue-resistance) than type II fibers (fatigable).26,37,38,70 This fiber-type shift may explain the 
inverse relationship between muscle strength and endurance in the elderly.  
The consistent findings of the studies that we have performed over the last four years to 
investigate the effects of knee OA on quadriceps fatigue implies that quadriceps fatigue, as we 
operationally defined and measured it, does not influence the function of individuals with knee 
OA.  Given this, the value of continued investigation of the effect of knee OA on quadriceps 
fatigue is limited.   
 
5.1.1.5 Magnitude of Cardiorespiratory Endurance   
Our results confirm previous findings that people with knee OA have impaired aerobic 
capacity.  Previous studies have shown that individuals with knee OA are markedly 
deconditioned compared to healthy, age-and sex-matched peers.9,96  Beals et al9 reported 
significant differences in VO2 max mean between subjects with knee OA and sedentary age-and 
sex-matched controls. The mean VO2 max was 17.8 ± 2.3 and 20.5 ± 2.1 ml/kg/min for knee OA 
and controls groups respectively (p <.05).  In a recent study by Philbin et al96 it was reported that 
patients with knee OA had significantly lower VO2 max mean scores compared to age-and sex-
matched controls (12.8 ± 3.7 versus 17.6 ± 5.2  ml/kg/min,  p <0.0005). In our study, VO2 max 
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in individuals with knee OA was 16.5 ± 5.6 ml/kg/min.  The values of VO2 max obtained in the 
three above studies were all lower than the published norms of VO2 max relative to age and sex, 
indicating lower fitness level for persons with knee OA.52     
      
5.1.1.6 Influence of Cardiorespiratory Endurance on Self-Reported Fatigue   
Results in this study demonstrated that fatigue was negatively related to cardiorespiratory 
endurance (r = -.55, p <.001), indicating that poor cardiorespiratory endurance was associated 
with greater self-reported fatigue.  However, hierarchical regression analysis revealed that 
adding cardiorespiratory endurance to the model after controlling for age, sex, pain, depression, 
and anxiety did not explain any additional variance in fatigue.  Although cardiorespiratory 
endurance is related to self-reported fatigue, it did not appear to influence fatigue after 
controlling for demographic, physiological, and psychosocial variables.  This is due to the fact 
that cardiorespiratory endurance was found to be related to sex (r = -.60, p <.001) (poorer 
cardiorespiratory endurance in females), pain (r = -.54, p<.001), depression (r = -.34, p =.03), 
and anxiety (r = -.35, p =.02).  These relationships precluded cardiorespiratory endurance from 
providing any additional contribution to the prediction of fatigue after those variables were 
added to the model.   
 
5.1.1.7 Functional Significance of Cardiorespiratory Endurance      
The functional significance of cardiorespiratory endurance was evident by its relationship 
with quadriceps muscle strength, physical function, and pain.  Cardiorespiratory endurance was 
found to be positively related to quadriceps muscle strength normalized to BMI (r = .66, p 
<.001), and negatively related to the degree of difficulty (r = -.35, p = .02), and pain (r = -.54, p < 
 68
.001) experienced during activities of daily living.  These relationships and the relationships 
between cardiorespiratory endurance, self-reported fatigue, depression, and anxiety seem to fit 
into the theoretical model put forward by Dekker et al36 to explain the role of muscle weakness 
in mediating the relationship between psychosocial variables and pain and disability experienced 
by individuals with osteoarthritis. It is hypothesized that patients with knee OA tend to avoid 
physical activity because increased levels of physical activity are associated with pain.  This in 
turn contributes to progressive muscle weakness and disability.  As a result, patients may feel 
frustrated and hopeless by this vicious cycle and be at risk of developing psychological distress.  
Depression and anxiety may serve to amplify this loop by increasing the degree of avoidance.  
Prolonged depression and anxiety may, by resulting in persistent attempts to avoid knee pain, 
lead to further muscle wasting, cardiovascular deconditioning and a sensation of generalized 
fatigue during normal activities of daily living.  Our data fully support this hypothesis.   
   
5.1.2 Implications for Physical Therapy  
 
The focus for health care providers in primary care is to minimize the consequences of 
chronic illness such as OA and maximize individual’s capability for independent living.29  Given 
this, and the results of this study which demonstrate the magnitude of fatigue, its association to 
psychosocial variables as well as to cardiorespiratory endurance, primary care health providers 
should attend to complaints of self-reported fatigue in OA population.  Individuals with 
characteristics similar to those that participated in this study may benefit from strategies to 
reduce the sensation of fatigue through better management of pain, psychosocial issues, and/or 
cardiorespiratory endurance. 
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The findings that self-reported fatigue, pain, and physical function were related to 
quadriceps strength but not to quadriceps fatigue have implications for physical therapy 
management of patients with knee OA.  In particular, these data indicate that exercises to 
improve quadriceps function should be focused at increasing strength (i.e. torque production) not 
endurance (i.e. the ability to sustain torque production).  Often physical therapy programs for 
individuals with knee OA include low to moderate resistance-high repetition exercises for the 
quadriceps, which are aimed at improving the ability to sustain torque production.  Focusing 
quadriceps exercises on high resistance-low repetition exercises (i.e. exercises with resistance 
that subjects can perform for 6 to 8 repetitions) may be more advantageous for patients with knee 
OA.  Further research is needed to test this hypothesis.   
      
5.1.3 Recommendations for Further Studies  
This study explored fatigue in individuals with knee OA using a one group cross-
sectional research design.  The results of the study revealed the magnitude and dimensions of 
fatigue in individuals with knee OA. The level of self-reported fatigue that we observed in 
individuals with knee OA appears to be greater than the fatigue observed in normal healthy 
individuals, although the control group used for this comparison was younger.  Therefore, future 
research is warranted to explore fatigue using a case-control design research. Future research is 
also warranted to test the hypothesized role of psychosocial variables in modifying the 
relationship between quadriceps strength and/or cardiorespiratory endurance with pain and 
physical function.   
Data from this study indicated that the primary muscle dysfunction in individuals with 
knee OA was a deficit in quadriceps strength and not quadriceps fatigue.  Traditionally exercises 
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to improve quadriceps function in individuals with knee OA have made use of low to moderate 
resistance-high repetition exercises, which would be expected to primarily address quadriceps 
fatigue, not deficits in quadriceps strength.  Exercises aimed at improving quadriceps strength 
should make use of relatively high resistance performed for few repetitions.  To determine which 
mode of exercise is most beneficial for individuals with knee OA that have quadriceps weakness, 
a randomized clinical trial is needed to investigate the effect of high resistance-low repetition 
exercises versus low to moderate resistance-high repetition exercises for the quadriceps on pain 
and physical function in individuals with knee OA.          
 
 
5.1.4 Conclusion 
This cross-sectional study was an initial attempt to explore self-reported fatigue in 
individuals with knee OA.  The results of this study demonstrated that fatigue is common in 
individuals with knee OA. Quadriceps fatigue is not related to fatigue.  Cardiorespiratory 
endurance is related to fatigue, but not after controlling for age, sex, pain, depression, and 
anxiety. 
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Table 1.  Demographic Characteristics (n=44)    
 
 Mean SD Range Number % 
Age (yrs) 65.32 8.9 50-86   
 
Sex 
     
Female    33 75 
Male    11 25 
      
Marital Status:      
Single    1 2.3 
Married    30 68.2 
Divorced/Separated    5 11.4 
Widowed    8 18.2 
      
Education:      
Less than high school    0 0 
High School graduate    13 29.5 
Some college    12 27.3 
College graduate    7 15.9 
Some post-graduate education    1 2.3 
Post-graduate degree    11 25.0 
      
Employment:      
Full time regular duty    13 29.5 
Part time regular duty    4 9.1 
Light duty or part time modified duty    2 4.5 
Unable to work or retired due to health status    3 6.8 
Retired    17 38.6 
Homemaker    1 2.3 
Unemployed    4 9.1 
      
Work type:      
Mostly sedentary    16 36.4 
Somewhat sedentary with substantial walking required    3 6.8 
Moderately active, walking, some lifting and carrying    22 50.0 
Demanding physical activity, heavy lifting and carrying    3 6.8 
      
Years with knee OA:      
Less than 1 year    0 0 
1-2 years    1 2.3 
3-5 years    12 27.3 
5-10 years    19 43.2 
More than 10 years    12 27.3 
      
Current Exercise:      
Walking    21 47.7 
Jogging    2 4.5 
Stretching    21 47.7 
Step Machine     12 27.3 
Weights    11 25 
Aerobic exercise    4 9.1 
Water exercise    13 29.5 
      
 (Return to page 39, 55) 
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Table 2.  Parameters for Multiple Regression Power Analysis    
Assumptions  
Alpha 0.05 
Power 0.80 
Covariates  
Number of variables 5 
R2 0.49 
Main set  
Number of variables 1 
Increment to R2 0.10 
Total Model  
Number of variables 6 
R2 0.59 
Outcome  
Sample size 40 
 
 
(Return to page 53)   
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Table 3.  Means and Standard Deviations of Fatigue Scores  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Descriptor 
 
Mean 
 
SD 
 
Observed Range 
    
GFIa 
 
23.6 10.4 1-40b
Degree 
 
5.3 2.1 1-10c
Severity 
 
4.6 2.5 1-9c
Distress 
 
4.1 2.7 1-10c
Impact 
 
3.3 1.7 1-8.5c
Timing 
 
6.3 3.0 1-10c
a GFI = Global Fatigue Index 
b Possible range of scores 1 (no fatigue) to 50 (extreme fatigue) 
c Possible range of scores 1 (not at all) to 10 (great deal) 
 
 
 
 
 
 
 
 
(Return to page 56) 
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Table 4.  Means and Standard Deviations (SD) of Males and Females Fatigue Scores   
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Descriptor 
 
Males (n=11) 
 
Mean (SD) 
 
Females (n= 33) 
 
Mean (SD) 
 
 
 
t 
 
 
 
p  value* 
     
GFI
 
14.3 (10.3) 26.7 (8.5) -3.59 <.01 
Degree 
 
3.8 (2.4) 5.8 (1.7) -2.52  <.05 
Severity 
 
2.6 (2.3) 5.2 (2.2) -3.21  <.01 
Distress 
 
1.6 (1.5) 4.9 (2.6) -4.95 <.001 
Impact 
 
2.2 (1.8) 3.7 (1.5) -2.66 <.05 
Timing 4.1 (3.4) 7.0 (2.5) -2.64 <.05 
 
 
 
* Significance tested with independent samples t-test 
 
(Return to page 56) 
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Table 5.  Means and Standard Deviations of Factors Associated with Fatigue   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Return to page 56)
 
Variables 
 
Mean 
 
SD 
 
Observed Range 
    
Pain
 
6.7 3.8 0-14a
Depression 
 
10.5 8.4 0-39b
Anxiety 
 
7.1 6.3 0-28c
Cardiorespiratory Enduranced 
 
16.5 5.6 9.4-30.9 
Quadriceps Fatiguee 
 
7.1 5.1 0.98-21.9 
 Possible range of scores; a (0-20), b (0-60), c(0-63)  
d Measured as maximum oxygen consumption (VO2 max) (ml/kg/min) 
e Measured as rate of decline of maximum voluntary isometric contraction (MVIC) (%/min) 
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Table 6.  Means and Standard Deviations of the Rates of Decline in Maximum Voluntary 
Isometric Contraction (MVIC) and Superimposed Electrical Stimulation (SES) Torques at 2, 5, 
and 7 Minutes of the Fatigue Task.  
 
 
Time (min) 
MVIC 
 
Mean ± SD 
SES 
 
Mean ± SD 
 
 
t 
 
 
p value* 
2 11.56 ± 5.3 
 
9.03 ± 3.7 
 
 
4.79 <.001 
5 7.75 ± 4.6 6.2 ± 3.2  4.12 <.001 
7 5.87 ± 3.4 
 
4.72 ± 3.2 
 
 
2.03 <.05 
* Significance tested with paired samples t-test  
 
 
 
 
 
(Return to page 57)  
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Table 7.  Bivariate Associations among Variables (n=44) 
 
 
 
 
 
GFI 
 
Age 
 
Sex 
 
Pain 
 
Depression
 
Anxiety 
 
CREa 
 
 
QFb 
 
         
GFI
 
1 -.04 .52** .62** .47** .54** -.55** .01 
Age  
 
 1 -.06 .24 .07 .10 -.07 .24 
Sex 
 
  1 .34* ..19 .21 -.60** .11 
Pain 
 
   1 .33* .56** -.54** -.05 
Depression 
 
    1 .54** -.34* .18 
Anxiety 
 
     1 -.35* .09 
CREa 
 
      1 -.18 
QFb 
 
       1 
*    Pearson Product Moment Correlation (p <.05)    (2-tailed) 
**  Pearson Product Moment Correlation (p <.001)  (2-tailed) 
a       Cardiorespiratory Endurance 
b     Quadriceps fatigue 
 
  
 
 
(Return page 57, 61, 65) 
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Table 8.  Means (SD) of Fatigue Scores for OA Patients and Controlsa    
a  Controls fatigue scores were obtained from a previous study by Belza12  
 
 
 
Descriptor 
 
OA (n=44) 
 
Mean (SD) 
 
Controls (n= 46) 
 
Mean (SD) 
 
 
 
t 
 
 
 
p  value* 
     
GFI
 
23.6 (10.4) 16.4 (11.5) 3.11 < 0.01 
Degree 
 
5.3 (2.1) 4.2 (2.0) 2.56  < 0.05 
Severity 
 
4.6 (2.5) 3.2 (1.9) 3.02  < 0.01 
Distress 
 
4.1 (2.7) 3.0 (1.8) 2.29 < 0.05 
Impact 
 
3.3 (1.7) 2.6 (1.7) 1.97 < 0.05 
Timing 
 
6.3 (3.0) 5.3 (2.3) 1.80 < 0.05 
* Significance tested with independent samples t-test 
 
 
 
(Return to page 58)
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    Table 9.  Means (SD) of Fatigue Scores for OA and RA Patientsa   
       a   RA fatigue scores were obtained from a previous study by Belza12 
 
 
 
Descriptor 
 
OA (n=44) 
 
Mean (SD) 
 
RA (n= 51) 
 
Mean (SD) 
 
 
 
t 
 
 
 
p value* 
     
GFI
 
23.6 (10.4) 27.8 (10.5) -1.96 < 0.05 
Degree 
 
5.3 (2.1) 6.3 (1.7) -2.57  < 0.05 
Severity 
 
4.6 (2.5) 5.4 (1.8) -1.81 < 0.05 
Distress 
 
4.1 (2.7) 4.9 (1.7) -1.76 < 0.05 
Impact 
 
3.3 (1.7) 4.2 (2.1) -2.28 < 0.05 
Timing 
 
6.3 (3.0) 7.3 (2.1) -1.91 < 0.05 
    * Significance tested with independent samples t-test 
 
 
 
 
   (Return to page 58)
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       Table 10. Hierarchical Regression Analysis: Influence of QFa on GFIb.  
        a   QF = Quadriceps Fatigue 
 
Model 
 
R2
 
R2 ∆ 
 
F -Ratio 
 
p Value 
     
Model 1     
(Age+ Sex + Pain+ Depression + Anxiety) .55 .55 9.12 < .001 
     
Model 2     
(Age +Sex + Pain + Depression + Anxiety +QF ) .55 .00 .12 .732 
     
              b   GFI = Global Fatigue Index  
 
 
 
 
 
(Return to page 59)
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    Table 11.  Standardized Beta Coefficients for the model including QFa  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Return to page 59)
 
Variables 
 
Standardized Beta 
 
t 
 
p value 
Age -.183 -1.5 >.05 
Sex .280 2.3 <.05 
Pain .399 2.7 .<.01 
Depression .198 1.5 >.05 
Anxiety .157 1.1 >.05 
QF .042 .35 >.05 
a Quadriceps Fatigue  
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Table 12. Hierarchical Regression Analysis: Influence of CREa on GFIb.   
Model 
 
R2
 
R2 ∆ 
 
F -Ratio 
 
p Value 
     
Model 1     
(Age+ Sex + Pain+ Depression + Anxiety) .61 .61 11.75 < .001 
     
Model 2     
(Age +Sex + Pain + Depression + Anxiety +CRE ) .62 .01 .18 .673 a   CRE  = Cardiorespiratory Endurance 
b   GFI  = Global Fatigue Index 
 
 
 
 
 
 
(Return to page 59)
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     Table 13. Standardized Beta Coefficients for the model including CERa 
 
 
Variables 
 
Standardized Beta 
 
t 
 
p value 
Age -.151 -1.4 >.05 
Sex .298 2.3 <.05 
Pain .367 2.6 <.05 
Depression .182 1.4 >.05 
Anxiety .180 1.3 >.05 
CRE -.062 -.43 >.05 
a Cardiorespiratory Endurance  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
(Return to page 60)  
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 Table 14.  Stepwise Regression Analysis to determine the “best” model 
 
  
Variables 
 
Standardized Beta 
 
t 
 
p value 
Step 1 Pain .42 3.45 <.01 
Step 2 Sex .34 2.88 <.01 
Step 3 Depression .26 2.25 <.05 
  
Overall R2 = .53 
 
 
 
 
 
 
(Return to page 60)
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INITIAL WORKLOAD
25 W 
 
 
Figure 1. Schematic Illustration of the Cardiorespiratory Endurance Test 
 
 
 
(Return to page 47)
 
 
 
 
 
 
 
 
 
 
 
 
INCREASE WORKLOAD 
BY 25 W 
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TARGET HR IS 
ACHIEVED 
HR <70% APMHR HR ≥70% APMHR 
STOP
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  Figure 2.  A schematic Illustration of the Quadriceps Fatigue Test. 
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Figure 4.  Maximum Voluntary Isometric Contraction (MVIC) and Superimposed Electrical 
Stimulation torques over time during repeated isometric contractions at 50% of SES.  Data 
represents aggregate data across all 43 subjects at endurance time.  Each data point represents 
mean ± SE of the corresponding torque at one minute intervals.   
* Significant difference between rates of decline in torques at each subject’s endurance time (p < 
.001).  
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                 Figure 5.  Histogram of time to fatigue during quadriceps fatigue test 
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APPENDIX A 
 
LETTER TO POTENTIAL SUBJECTS 
 
Dear Research Participant 
 
We are currently conducting a study in the Department of Physical Therapy at the University of 
Pittsburgh School of Health and Rehabilitation Sciences.  The purpose of this research study is to look at 
the level of fatigue in individuals with knee osteoarthritis.  Specifically, we want to determine if 
individuals with knee osteoarthritis frequently complain of fatigue and to determine the relationship 
between fatigue and age, gender, pain, depression, anxiety, aerobic capacity and thigh muscle fatigue.  
The result of this study will allow us to develop improved exercise programs for the treatment and 
prevention of arthritis affecting the knee.     
 
Because you have participated in our previous studies and were diagnosed with knee osteoarthritis, we 
would like to invite you to participate in this new study which is part of a series of studies we are 
conducting related to knee osteoarthritis.     
 
Participation in this study requires you to attend two testing sessions at University of Pittsburgh Medical 
Center (UPMC) Center for Sports Medicine (see directions on the back).  The first testing session will 
last approximately 90 minutes and the second session will last approximately 30 minutes.  You will be 
reimbursed $20 for each session for a total of $40 for your time and travel. 
 
During the first session, you will be asked to complete several questionnaires regarding your current level 
of fatigue and pain, your mood state including levels of depression and anxiety, levels of nervousness and 
fear of pain and further injury to your knee.  You will undergo a test on a bike in which you will pedal at 
a moderate level of exertion to measure your fitness and a test to measure the strength of your thigh 
muscle.  During the strength test you will be asked to straighten your knee as hard as possible and a very 
brief electrical stimulus will be applied to your thigh ensure that you are pushing with maximum effort.   
 
During the second testing session, you will undergo a test to determine the endurance of your thigh 
muscle.  During this test you will repeatedly attempt to straighten your knee with a submaximal effort 
until you are no longer able to generate 50% of your maximal strength and a very brief electrical stimulus 
will be applied to your thigh ensure that your thigh muscle have fatigued.  
 
If you are interested to participate or you would like further information concerning this study, you can 
contact FAWZI at (412) 383-6712.  We hope that you will consider participating in the study. 
 
 
Sincerely, 
 
 
James Irrgang PhD, PT, ATC     Kelley Fitzgerald, PhD, PT, OCS  
Assistant Professor      Assistant Professor 
Department of Physical Therapy     Department of Physical Therapy 
School of Health and Rehabilitation     School of Health and Rehabilitation 
University of Pittsburgh      University of Pittsburgh 
 
 
(Return to page 38)
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APPENDIX B 
 
MEDICAL RELEASE FORM  
 
 
MEMORANDUM 
 
TO: 
FROM:         Fawzi Bouzubar MS, PT and James Irrgang, PhD, PT, ATC 
DATE: 
RE:          Patient Participation in a Research Study 
CC: 
We are conducting a research study that has been approved by the University of Pittsburgh IRB 
to describe the prevalence of self-reported fatigue in individuals with knee osteoarthritis and to 
determine the relationships between fatigue and age, gender, pain, negative affect, 
cardiorespiratory endurance and neuromuscular fatigue of the quadriceps. Your patient, 
________________________________ has agreed to volunteer as a subject in this study.  
Before scheduling your patient for testing, we want to be certain that there are no medical 
conditions that you believe would prevent your patient from safely participating in the study.  
The study is described below.   
Please return this form by fax at your earliest convenience so that we may schedule test sessions 
as soon as possible. Our fax number is 412-383-6629.  If you have further questions, I can be 
contacted at 412-383- 6712.  Thank you for your assistance with this project. 
 
Please indicate if you believe there are any medical conditions that would prevent your patient 
from participating in the study. 
_____ The above named patient may participate in the study. 
_____ The above named patient may not participate in the study for the following 
reason: 
 
 
Description of Study: 
Your patient will participate in two testing sessions.  During the first session, the patient will fill 
out a series of questionnaires related to fatigue, pain and negative affect. Then he/she will 
undergo a quadriceps femoris strength test in which a brief electrical stimulus will be 
superimposed on the patient’s voluntary maximum isometric contraction of the quadriceps 
muscle.  This procedure will allow us to determine the maximal voluntary contraction torque 
output that will be used in the quadriceps fatigue test during the second session.  Finally in the 
first testing session, the patient will perform a submaximal cycle ergometer test to estimate 
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VO2 max as a measure of cardiorespiratory endurance.  The submaximal exercise test will be 
terminated if systolic blood pressure fails to increase with increased exercise intensity or if 
systolic blood pressure exceeds 170 mm Hg or diastolic blood pressure exceeds 110 mm Hg or if 
the heart rate exceeds 85% of the subject’s age-predicted maximum value.  This test will take 
approximately 5 to 10 minutes to complete.  
The second session will be scheduled within one week after completing the first testing session.  
During the second session, the patient will perform a quadriceps fatigue test, in which the 
patient will perform submaximal isometric contractions of the quadriceps at 50% of his/her 
maximum voluntary isometric torque for 6 seconds followed by a 4-second rest period.  The 
contractions will be continued for a minimum of 5 minutes.  The test will be stopped after 5 
minutes if the subject can no longer generate torque output equal to 50% of the maximum 
isometric torque output, otherwise the subject will continue the contractions until he/she can 
longer generate the target torque for successive contractions.  During the sixth contraction and 
every minute thereafter, subjects will be instructed to push with a maximum effort and a burst of 
electrical stimulation will be superimposed upon the maximal effort of quadriceps contraction. 
The quadriceps fatigue test will be terminated if systolic blood pressure exceeds 170 mm Hg, if 
diastolic blood pressure exceeds 110 mm Hg or if heart rate exceeds 85% of the age predicted 
maximum value.   
 
 
 
__________________________                                     Date:____________________ 
 (Physician’s Signature) 
 
 
(Return to page 38)
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APPENDIX C 
 
INCLUSION/EXCLUSION CRITERIA FORM 
Subject ID:_______________________                                             
 
Inclusion Criteria:  
 Yes No 
Age 45 or older?  ? ? 
Diagnosed with Knee OA? ? ? 
If yes, please complete the following:    
? Meets 1986 ACR criteria (Knee pain and at least 3 of the following):   
1. Age 50 or older? ? ? 
2. Morning stiffness less than 30 minutes?   ? ? 
3. Crepitus with active motion of the knee (i.e. squatting)? ? ? 
4. Tenderness of bony margins of the joint?  ? ? 
5. Bony enlargement noted on examination? ? ? 
6. Lack of palpable warmth of the synovium? ? ? 
   
   
Exclusion Criteria:   
 Yes No 
Knee flexion ROM < 70º? ? ? 
Undergone total knee arthroplasty? ? ? 
Uncontrolled hypertension? (i.e. systolic blood pressure greater than 140 mm Hg or diastolic 
blood pressure greater than 90 mm Hg) ? ? 
History of cardiovascular disease? (e.g. myocardial infarction, angina, arrhythmias, stroke) ? ? 
History of patellar or quadriceps tendon rupture? ? ? 
History of patellar fracture? ? ? 
Have had any surgical procedures involving the patella, quadriceps tendon or patellar tendon?  ? ? 
Have had a steroid injection of the patellar or quadriceps tendons in the past 6 months? ? ? 
Pregnant female? ? ? 
If no, Post-Menopausal for at least one year?  ? ? 
Home pregnancy test positive? ? ? 
 
 
? Subject meets all inclusion/exclusion criteria and is eligible for participation in study  
? Subject does not meet all inclusion/exclusion criteria and is not eligible for participation in study  
 
_____________________                                                                  ______________ 
Investigator reviewing                                                                         Date 
Inclusion/Exclusion criteria 
 
(Return to page 39)
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APPENDIX D 
 
SUBJECT DEMOGRAPHIC DATA SHEET 
 
Subject ID #:______________                                       Date:_________________ 
 
Age:________             Height (cm):___________          Weight (kg):___________ 
 
2. Sex: 
⎯ Male  
⎯ Female     
 
3. Involved Knee: 
 
⎯ Right  
⎯ Left 
⎯ Both (If both, which one causes more pain and disability: ___Right ___left) 
 
4. List other joints in your body with osteoarthritis: 
 
 
 
 
 
 
 
 
5. Ethnic Origin: 
 
⎯ Black/African American 
⎯ Hispanic 
⎯ Asian/Pacific Islander 
⎯ Native American 
⎯ White/Caucasian 
⎯ Other 
 
6. Marital Status: 
 
⎯ Married 
⎯ Living with significant other 
⎯ Divorced 
⎯ Widowed 
⎯ Single(never married) 
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7. Level of education (Mark the highest level obtained): 
 
⎯ Less than high school 
⎯ Graduated from high school 
⎯ Some college 
⎯ Graduated from college 
⎯ Some post-graduated course work 
⎯ Completed post-graduated degree 
 
8. Current Employment Status (Check one category that best describes current work 
status): 
 
⎯ Work regular duty full time 
⎯ Work regular duty part time 
⎯ Work light duty or modified position full time 
⎯ Temporary unable to work due to health status 
⎯ Permanently unable to work or retired due to health status 
⎯ Retired (not due to health status) 
⎯ Unemployed 
⎯ Homemaker (not working outside the home) 
⎯ Student (not currently working) 
 
9. Which statement best describes the type of work you do (or used to do): 
 
⎯ Mostly sedentary 
⎯ Sedentary; substantial amount of walking required 
⎯ Moderately active; walking, some lifting and carrying 
⎯ Demanding physical activity, heavy lifting and carrying 
 
10.  Have you smoked at least 100 cigarettes in you entire life? 
 
⎯ Yes (go to question 11) 
⎯ No (go to question 14) 
⎯ Don’t know (go to question 14) 
 
11. If yes, on the average during all the years that you have smoked, how many cigarettes 
have you usually smoked per day? 
 
⎯ 1-10 
⎯ 11-20 
⎯ 21-40 
⎯ More than 40 
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12. If yes, do you smoke cigarettes now? 
 
⎯ Yes 
⎯ No 
 
13. If yes, except for the time you quit, for how many years all together have you smoked 
cigarettes? 
 
⎯ 0-5 years 
⎯ 6-10 years 
⎯ 11-20 
⎯ More than 20 years 
 
14. The following are a list of health problems. Do you currently have, or have previously 
had the problems? 
 
a. Heart                                 ⎯ Yes ⎯ No 
b. High Blood Pressure  ⎯ Yes ⎯ No 
c. Stroke  ⎯ Yes ⎯ No 
d. Congestive Heart Failure ⎯ Yes ⎯ No 
e. Lung Disease ⎯ Yes ⎯ No 
f.  Diabetes ⎯ Yes ⎯ No 
g. Stomach ulcer ⎯ Yes ⎯ No 
h. Kidney Disease ⎯ Yes ⎯ No 
i. Liver Disease ⎯ Yes ⎯ No 
j. Anemia or other Blood Disease ⎯ Yes ⎯ No 
k. Cancer ⎯ Yes ⎯ No 
l. Depression ⎯ Yes ⎯ No 
m. Back Pain ⎯ Yes ⎯ No 
n. Memory Problem ⎯ Yes ⎯ No 
o. Previous Hip Fracture ⎯ Yes ⎯ No 
p. Other medical Problems ⎯ Yes ⎯ No 
 
15. How long have you had symptoms (pain) of arthritis in your knee? 
 
⎯ Less than 1 year 
⎯ 1-2 years 
⎯ 3-5 years  
⎯ 5-10 years 
⎯ More than 10 years 
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16. When did you first see a physician about arthritis in your knee? 
 
⎯ Less than 1 year 
⎯ 1-2 years 
⎯ 3-5 years  
⎯ 5-10 years 
⎯ More than 10 years 
 
17. Prior knee injuries or surgeries (please provide type of injury or surgery and date or 
estimate date) 
 
a. Type:________________________________       Date:_____________ 
b. Type:________________________________       Date:_____________  
c. Type:________________________________       Date:_____________ 
d. Type:________________________________       Date:_____________  
e. Type:________________________________       Date:_____________  
 
18. Current medications for knee osteoarthritis: 
 
⎯ a. Over the counter analgesics (Tylenol, Aspirin_free tablets, etc.) 
⎯ b. Arthritis creams 
⎯ c. Over the counter non-steroids (aspirin, Ibuprofen, Aleve, Orudis, etc.) 
⎯ d. Prescription analgesics (Codeine, Percocet, Darvocet, Ultram, etc.) 
⎯ e. Prescription non-steriodals (Celebrex, Voltaren, Naprosyn, Daypro, Ibuprefen,     
          Lodine, Oruvial) 
⎯ f. Other:_________________________________________  
 
19. Please list other Medications you take for conditions other than osteoarthritis of your 
knee.  
a.  
b.  
c.  
d.  
 
20. Current exercise to help lessen the pain and stiffness of arthritis? 
 
a. Walking program  ⎯ Yes ⎯ No 
b. Jogging program  ⎯ Yes ⎯ No 
c. Stretching exercise, Yoga ⎯ Yes ⎯ No 
d. Treadmill, Nordic Trak, Stairmaster, etc. ⎯ Yes ⎯ No 
e. Weight Machines ⎯ Yes ⎯ No 
f. Aerobics ⎯ Yes ⎯ No 
g. Water exercises ⎯ Yes ⎯ No 
 
(Return to page 40) 
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APPENDIX E   
 
MULTIDIMENSIONAL ASSESSMENT OF FATIGUE (MAF) SCALE 
 
 
Subject ID #:_______________________           Date:_________________ 
 
Instructions: These questions are about fatigue and the effect of fatigue on your activities. 
 
For each of the following questions, circle the number that most closely indicates how you have 
been feeling during the past week. 
 
For example, suppose you really like to sleep late in the mornings. You would probably circle the number 
closer to the "a great deal" end of the line. This is where I put it: 
 
Example: To what degree do you usually like to sleep late in the mornings? 
 
 
1  2  3  4  5  6  7  8  9  10
         Not at all            A great deal 
 
 
Now please complete the following items based on the past week. 
 
 
1. To what degree have you experienced fatigue? 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
If no fatigue, stop here. 
 
 
2. How severe is the fatigue which you have been experiencing? 
 
 
1  2  3  4  5  6  7  8  9  10
Mild                                                                                                                Severe 
 
 
3. To what degree has fatigue caused you distress? 
 
 
1  2  3  4  5  6  7  8  9  10
        No distress A great deal 
  of distress 
 
 
CONTINUED ON NEXT PAGE →  
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MULTIDIMENSIONAL ASSESSMENT OF FATIGUE (MAF) SCALE (Continued) 
 
Circle the number that most closely indicates to what degree fatigue has interfered with your ability to do the 
following activities in the past week. For activities you don't do, for reasons other than fatigue (e.g. you don't 
work because you are retired), check the box. 
 
In the past week, to what degree has fatigue interfered with your ability to: 
 
(NOTE: Check box to the left of each number if you don't do activity) 
 
? 4. Do household chores 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 5. Cook 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 6. Bathe or wash 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 7. Dress 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 8. Work 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 9. Visit or socialize with friends or family 
 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
 
CONTINUED ON NEXT PAGE →  
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MULTIDIMENSIONAL ASSESSMENT OF FATIGUE (MAF) SCALE (Continued) 
 
(NOTE: Check box to the left of each number if you don't do activity) 
 
? 10. Engage in sexual activity 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 11. Engage in leisure and recreational activities 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 12. Shop and do errands 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 13. Walk 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
? 14. Exercise, other than walking 
 
1  2  3  4  5  6  7  8  9  10
Not at all  A great deal 
 
 
15. Over the past week, how often have you been fatigued? 
 
4  Every day 
3  Most, but not all days 
2  Occasionally, but not most days 
1  Hardly any days 
 
16. To what degree has your fatigue changed during the past week? 
 
4  Increased 
3  Fatigue has gone up and down 
2  Stayed the same 
1  Decreased 
 
(Return to page 40) 
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APPENDIX F 
 
BURST SUPERIMPOSITION MVC TEST DATA FORM 
 
Subject ID:___________________________________ Date:__________________________ 
Involved Extremity:        R             L Limb Weight (NM):_______________
Weight (kg):_________  Height (cm):_________    BMI (W/H2): __________     Age:________ 
B.P.: _______/_______mmHG            H.R.: __________bpm           Rhythm: (    )Reg.  (    )Irr.  
 
Biodex Moment Arm:__________ 
  
Biodex Chair Back:____________   
Biodex Chair Height:___________   
Biodex Chair Floor:____________   
Dynamometer Position:_________   
   
Resting E-stim Torque (Nm):_________  
Practice MVC (Nm):___________   
   
Trial 1: 
 Torque Torque / BMI 
E-stim Torque   
Voluntary Torque   
Voluntary/E-stim   
 
Trial 2: 
 Torque Torque / BMI 
E-stim Torque   
Voluntary Torque   
Voluntary/E-stim   
 
Trial 3: 
 Torque Torque / BMI 
E-stim Torque   
Voluntary Torque   
Voluntary/E-stim   
 
Trial 4: 
  Torque Torque / BMI 
E-stim Torque   
Voluntary Torque   
Voluntary/E-stim   
 
 
 
 
(Return to page 46)
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APPENDIX G  
 
SUBMAXIMAL CYCLE ERGOMETER TEST DATA SHEET 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(R
  
 
 
 
  
 
 
Subject ID #:___________                                                     Date:______________ 
 
Gender:            F            M    
 
Age: ________yrs 
 
  
70% of APMHR:________ bpm                                             85% of APMHR:_________ bpm 
 
Pre-exercise HR: _______ bpm                                             Pre-exercise BP_____/_____mmHg 
 
 
HR BP 
1 min_________ bpm _____/____mmHg 
2 min_________ bpm _____/____mmHg  
3 min_________ bpm _____/____mmHg  
4 min_________ bpm _____/____mmHg  
5 min_________ bpm _____/____mmHg  
6 min_________ bpm _____/____mmHg  
7 min_________ bpm _____/____mmHg  
8 min_________ bpm _____/____mmHg  
9 min_________ bpm _____/____mmHg  
10 min_________ bpm 
 
_____/____mmHg  
 
Average HR __________  bpm                                             Post-exercise BP:_____/_____ mmHg 
 
Test duration: __________min                                              Final workload  __________Watts 
    
Preliminary VO2 max _______________ L/min 
 
 (Men       VO2 max= 0.348(Prel. VO2 max) -0.035(age)+3.011)        
(Women   VO2 max=0.302(Prel. VO2 max)-0.019(age)+1.593) 
 
Age & gender corrected VO2 max ____________ L/min 
 
VO2 max ___________mL/kg/min         (VO2 max *1000/kg)   
 
 
 
 
 
 
 
 
 
eturn to page 48)
 
Rating:   
      
1. Excellent 
2. Good 
3. Above average 
4. Average 
5. Below average 
6. Poor 
7. Very poor 
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APPENDIX H 
  
QUADRICEPS FATIGUE TEST DATA FORM 
 
Subject ID:_______________________  Date:_______________________                   
  
Involved Extremity:    R             L                  Limb Weight (Nm):_________ 
                                                             
Maximum Voluntary Torque (Nm):___________ 
 
Maximum E-stim Torque (Nm):_______________  
 
Resting E-stim Torque (Nm):__________ 
 
CAR (%):_____________ 
 
 
 
Time (min) E-stim Torque Voluntary Torque 
   
   
   
   
   
   
   
   
   
   
  
(Return to page 50)
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